> top > docs > PMC:7029759 > annotations

PMC:7029759 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
67 2223-2232 Disease denotes pneumonia MESH:D011014
162 5998-6007 Species denotes 2019-nCoV Tax:2697049
1 60-77 Species denotes novel coronavirus Tax:2697049
26 1341-1372 Gene denotes angiotensin-converting enzyme 2 Gene:59272
27 1374-1378 Gene denotes ACE2 Gene:59272
28 1419-1423 Gene denotes ACE2 Gene:59272
29 1589-1593 Gene denotes ACE2 Gene:59272
30 1637-1641 Gene denotes ACE2 Gene:59272
31 1801-1805 Gene denotes ACE2 Gene:59272
32 155-172 Species denotes novel coronavirus Tax:2697049
33 174-183 Species denotes 2019-nCoV Tax:2697049
34 563-572 Species denotes 2019-nCoV Tax:2697049
35 642-650 Species denotes patients Tax:9606
36 729-738 Species denotes 2019-nCoV Tax:2697049
37 742-750 Species denotes patients Tax:9606
38 1278-1287 Species denotes 2019-nCoV Tax:2697049
39 1954-1962 Species denotes patients Tax:9606
40 2076-2084 Species denotes patients Tax:9606
41 234-245 Species denotes respiratory Tax:12814
42 975-990 Chemical denotes oligonucleotide MESH:D009841
43 347-355 Disease denotes infected MESH:D007239
44 451-470 Disease denotes 2019-nCoV infection MESH:C000657245
45 578-587 Disease denotes infection MESH:D007239
46 674-679 Disease denotes death MESH:D003643
47 1669-1678 Disease denotes infection MESH:D007239
48 1706-1732 Disease denotes acute respiratory distress MESH:D012128
49 2067-2075 Disease denotes infected MESH:D007239
64 2378-2395 Species denotes novel coronavirus Tax:2697049
65 2397-2406 Species denotes 2019-nCoV Tax:2697049
66 2766-2772 Species denotes people Tax:9606
68 2314-2323 Disease denotes pneumonia MESH:D011014
69 2420-2453 Disease denotes Severe Acute Respiratory Syndrome MESH:D045169
70 2455-2459 Disease denotes SARS MESH:D045169
71 2467-2499 Disease denotes Middle East Respiratory Syndrome MESH:D018352
72 2501-2505 Disease denotes MERS MESH:D018352
73 2522-2526 Disease denotes SARS MESH:D045169
74 2531-2535 Disease denotes MERS MESH:D018352
75 2618-2622 Disease denotes SARS MESH:D045169
76 2740-2753 Disease denotes SARS infected MESH:D045169
77 2788-2794 Disease denotes deaths MESH:D003643
91 2851-2868 Species denotes novel coronavirus Tax:2697049
92 2870-2879 Species denotes 2019-nCoV Tax:2697049
93 2953-2958 Species denotes Human Tax:9606
94 2962-2967 Species denotes human Tax:9606
95 2984-2993 Species denotes 2019-nCoV Tax:2697049
96 3568-3579 Species denotes coronavirus Tax:11118
97 3177-3196 Disease denotes 2019-nCoV infection MESH:C000657245
98 3205-3210 Disease denotes fever MESH:D005334
99 3212-3217 Disease denotes cough MESH:D003371
100 3223-3230 Disease denotes myalgia MESH:D063806
101 3234-3241 Disease denotes fatigue MESH:D005221
102 3247-3256 Disease denotes pneumonia MESH:D011014
103 3654-3659 Disease denotes fever MESH:D005334
112 3839-3850 Species denotes Ebola virus Tax:1570291
113 3986-3993 Species denotes patient Tax:9606
114 4228-4233 Species denotes Ebola Tax:1570291
115 4367-4376 Species denotes 2019-nCoV Tax:2697049
116 3807-3811 Disease denotes SARS MESH:D045169
117 3952-3960 Disease denotes infected MESH:D007239
118 4141-4149 Disease denotes infected MESH:D007239
119 4220-4224 Disease denotes SARS MESH:D045169
138 5363-5364 Gene denotes S Gene:43740568
139 5356-5361 Gene denotes spike Gene:43740568
140 4405-4413 Species denotes patients Tax:9606
141 4656-4664 Species denotes patients Tax:9606
142 4885-4890 Species denotes Ebola Tax:1570291
143 5140-5149 Species denotes 2019-nCoV Tax:2697049
144 5151-5156 Species denotes Ebola Tax:1570291
145 5314-5323 Species denotes 2019-nCoV Tax:2697049
146 5381-5392 Species denotes coronavirus Tax:11118
147 5686-5695 Species denotes 2019-nCoV Tax:2697049
148 5741-5749 Species denotes patients Tax:9606
149 5764-5773 Species denotes 2019-nCoV Tax:2697049
150 5809-5814 Species denotes Ebola Tax:1570291
151 5815-5823 Species denotes patients Tax:9606
152 5520-5524 Disease denotes SARS MESH:D045169
153 5529-5533 Disease denotes MERS MESH:D018352
154 5750-5758 Disease denotes infected MESH:D007239
155 5403-5413 CellLine denotes MN908947.3 CVCL:U508
163 6075-6083 Species denotes patients Tax:9606
164 6160-6169 Species denotes 2019-nCoV Tax:2697049
165 6229-6238 Species denotes 2019-nCoV Tax:2697049
166 6263-6271 Species denotes patients Tax:9606
167 6446-6454 Species denotes patients Tax:9606
172 6585-6586 Gene denotes S Gene:43740568
173 6783-6784 Gene denotes S Gene:43740568
174 6551-6562 Species denotes Coronavirus Tax:11118
175 6843-6851 Disease denotes infected MESH:D007239
191 7354-7355 Gene denotes S Gene:43740568
192 7023-7024 Gene denotes S Gene:43740568
193 7051-7060 Species denotes 2019-nCoV Tax:2697049
194 7238-7247 Species denotes 2019-nCoV Tax:2697049
195 7414-7418 Species denotes mice Tax:10090
196 7422-7429 Species denotes rabbits Tax:9986
197 7535-7540 Species denotes yeast Tax:4932
198 7822-7831 Species denotes 2019-nCoV Tax:2697049
199 8066-8079 Species denotes coronaviruses Tax:11118
200 8465-8473 Species denotes patients Tax:9606
201 8698-8703 Species denotes yeast Tax:4932
202 8769-8777 Species denotes patients Tax:9606
203 7844-7853 Disease denotes infection MESH:D007239
204 8093-8097 Disease denotes SARS MESH:D045169
205 7258-7268 CellLine denotes MN908947.3 CVCL:U508
212 8852-8861 Species denotes 2019-nCoV Tax:2697049
213 8908-8913 Species denotes sheep Tax:9940
214 8921-8924 Species denotes cow Tax:9913
215 8935-8944 Species denotes 2019-nCoV Tax:2697049
216 9331-9336 Species denotes human Tax:9606
217 9577-9586 Species denotes 2019-nCoV Tax:2697049
220 9667-9676 Species denotes 2019-nCoV Tax:2697049
221 9642-9658 Chemical denotes oligonucleotides MESH:D009841
236 9729-9738 Species denotes 2019-nCoV Tax:2697049
237 9829-9838 Species denotes 2019-nCoV Tax:2697049
238 10158-10166 Species denotes CoV-2019 Tax:2697049
239 10357-10366 Species denotes 2019-nCoV Tax:2697049
240 10374-10384 Species denotes SARS virus Tax:694009
241 11113-11118 Species denotes Ebola Tax:1570291
242 9990-10006 Chemical denotes oligonucleotides MESH:D009841
243 10294-10309 Chemical denotes oligonucleotide MESH:D009841
244 10489-10505 Chemical denotes oligonucleotides MESH:D009841
245 10596-10601 Chemical denotes lipid MESH:D008055
246 10777-10786 Disease denotes infection MESH:D007239
247 11032-11047 Disease denotes viral infection MESH:D001102
248 11349-11357 Disease denotes infected MESH:D007239
249 9872-9882 CellLine denotes MN908947.3 CVCL:U508
265 11601-11610 Species denotes 2019-nCoV Tax:2697049
266 12183-12188 Species denotes Ebola Tax:1570291
267 12309-12317 Species denotes patients Tax:9606
268 12326-12335 Species denotes 2019-nCoV Tax:2697049
269 12496-12505 Species denotes 2019-nCoV Tax:2697049
270 12676-12685 Species denotes 2019-nCoV Tax:2697049
271 12930-12935 Species denotes mouse Tax:10090
272 13021-13034 Species denotes coronaviruses Tax:11118
273 13150-13159 Species denotes 2019-nCoV Tax:2697049
274 12435-12438 Species denotes HIV Tax:12721
275 12400-12409 Chemical denotes lopinavir MESH:D061466
276 12836-12846 Chemical denotes remdesivir MESH:C000606551
277 11871-11921 Disease denotes immunodeficiency virus (HIV) and hepatitis C virus MESH:D006526
278 12551-12555 Disease denotes SARS MESH:D045169
279 12922-12926 Disease denotes MERS MESH:D018352
281 13276-13283 Species denotes patient Tax:9606
291 13398-13406 Species denotes patients Tax:9606
292 13450-13458 Species denotes patients Tax:9606
293 13500-13508 Species denotes Patients Tax:9606
294 13621-13630 Species denotes 2019-nCoV Tax:2697049
295 13746-13754 Species denotes patients Tax:9606
296 13794-13803 Species denotes 2019-nCoV Tax:2697049
297 13523-13538 Disease denotes viral infection MESH:D001102
298 13727-13736 Disease denotes infection MESH:D007239
299 13769-13778 Disease denotes infection MESH:D007239
307 13830-13838 Species denotes Patients Tax:9606
308 13862-13871 Species denotes 2019-nCoV Tax:2697049
309 13951-13959 Species denotes patients Tax:9606
310 14232-14237 Species denotes Ebola Tax:1570291
311 14238-14246 Species denotes patients Tax:9606
312 13942-13950 Disease denotes infected MESH:D007239
313 14358-14366 Disease denotes infected MESH:D007239
322 14403-14411 Species denotes patients Tax:9606
323 14497-14506 Species denotes 2019-nCoV Tax:2697049
324 14600-14608 Species denotes patients Tax:9606
325 14778-14786 Species denotes patients Tax:9606
326 14848-14855 Species denotes patient Tax:9606
327 15030-15037 Species denotes patient Tax:9606
328 15070-15077 Species denotes patient Tax:9606
329 14425-14434 Disease denotes infection MESH:D007239
331 15184-15193 Species denotes 2019-nCoV Tax:2697049
334 15255-15264 Species denotes 2019-nCoV Tax:2697049
335 15723-15728 Species denotes Ebola Tax:1570291
350 16272-16303 Gene denotes angiotensin-converting enzyme 2 Gene:59272
351 16305-16309 Gene denotes ACE2 Gene:59272
352 16459-16463 Gene denotes ACE2 Gene:59272
353 16764-16768 Gene denotes ACE2 Gene:59272
354 16253-16262 Species denotes 2019-nCoV Tax:2697049
355 16380-16396 Species denotes SARS coronavirus Tax:694009
356 16438-16449 Species denotes coronavirus Tax:11118
357 16748-16757 Species denotes 2019-nCoV Tax:2697049
358 16876-16885 Species denotes 2019-nCoV Tax:2697049
359 16739-16743 Disease denotes SARS MESH:D045169
360 16846-16850 Disease denotes SARS MESH:D045169
361 16900-16904 Disease denotes SARS MESH:D045169
362 17023-17032 Disease denotes infection MESH:D007239
363 17036-17040 Disease denotes SARS MESH:D045169
365 17079-17083 Gene denotes ACE2 Gene:59272
371 17183-17187 Gene denotes ACE2 Gene:59272
372 17229-17233 Gene denotes ACE2 Gene:59272
373 17146-17154 Species denotes patients Tax:9606
374 17556-17571 Species denotes influenza virus Tax:11308
375 17686-17697 Chemical denotes sialic acid MESH:D019158
397 17793-17797 Gene denotes ACE2 Gene:59272
398 17938-17942 Gene denotes ACE2 Gene:59272
399 18188-18192 Gene denotes ACE2 Gene:59272
400 18435-18439 Gene denotes ACE2 Gene:59272
401 18482-18486 Gene denotes ACE2 Gene:59272
402 17872-17873 Gene denotes S Gene:43740568
403 18156-18164 Species denotes patients Tax:9606
404 18307-18316 Species denotes 2019-nCoV Tax:2697049
405 18394-18403 Species denotes 2019-nCoV Tax:2697049
406 18518-18529 Species denotes coronavirus Tax:11118
407 19454-19458 Species denotes mice Tax:10090
408 18513-18517 Species denotes NL63 Tax:277944
409 17867-17871 Disease denotes SARS MESH:D045169
410 18074-18078 Disease denotes SARS MESH:D045169
411 18129-18133 Disease denotes SARS MESH:D045169
412 18230-18239 Disease denotes infection MESH:D007239
413 18385-18389 Disease denotes SARS MESH:D045169
414 18504-18508 Disease denotes SARS MESH:D045169
415 19271-19275 Disease denotes MERS MESH:D018352
416 19281-19285 Disease denotes MERS MESH:D018352
417 19334-19349 Disease denotes viral infection MESH:D001102
419 19697-19706 Species denotes 2019-nCoV Tax:2697049
438 19753-19757 Gene denotes ACE2 Gene:59272
439 19886-19890 Gene denotes ACE2 Gene:59272
440 20145-20149 Gene denotes ACE2 Gene:59272
441 20244-20248 Gene denotes scFv Gene:652070
442 20280-20284 Gene denotes ACE2 Gene:59272
443 20467-20471 Gene denotes ACE2 Gene:59272
444 20528-20532 Gene denotes ACE2 Gene:59272
445 20430-20435 Gene denotes spike Gene:43740568
446 20069-20074 Gene denotes spike Gene:43740568
447 19829-19834 Gene denotes spike Gene:43740568
448 19807-19812 Species denotes human Tax:9606
449 19865-19876 Species denotes coronavirus Tax:11118
450 20096-20105 Species denotes 2019-nCoV Tax:2697049
451 20343-20354 Species denotes coronavirus Tax:11118
452 20385-20389 Gene denotes ACE2 Gene:59272
453 19894-19902 Disease denotes infected MESH:D007239
454 20003-20012 Disease denotes infection MESH:D007239
455 20088-20092 Disease denotes SARS MESH:D045169
468 20619-20623 Gene denotes ACE2 Gene:59272
469 20785-20789 Gene denotes ACE2 Gene:59272
470 21008-21012 Gene denotes ACE2 Gene:59272
471 21187-21191 Gene denotes ACE2 Gene:59272
472 21357-21361 Gene denotes ACE2 Gene:59272
473 21776-21780 Gene denotes scFv Gene:652070
474 21796-21800 Gene denotes ACE2 Gene:59272
475 21534-21543 Species denotes mammalian Tax:9606
476 21666-21674 Species denotes patients Tax:9606
477 20652-20671 Disease denotes 2019-nCoV infection MESH:C000657245
478 20730-20734 Disease denotes SARS MESH:D045169
479 21292-21304 Disease denotes inflammation MESH:D007249
503 22671-22675 Gene denotes ACE2 Gene:59272
504 22762-22766 Gene denotes ACE2 Gene:59272
505 22855-22859 Gene denotes ACE2 Gene:59272
506 23081-23085 Gene denotes ACE2 Gene:59272
507 23267-23271 Gene denotes ACE2 Gene:59272
508 23425-23429 Gene denotes ACE2 Gene:59272
509 23572-23576 Gene denotes ACE2 Gene:70008
510 23653-23657 Gene denotes ACE2 Gene:70008
511 23758-23762 Gene denotes ACE2 Gene:70008
512 22296-22305 Species denotes 2019-nCoV Tax:2697049
513 22465-22474 Species denotes 2019-nCoV Tax:2697049
514 23580-23586 Species denotes murine Tax:10090
515 23919-23927 Species denotes patients Tax:9606
516 22136-22140 Disease denotes SARS MESH:D045169
517 22211-22215 Disease denotes SARS MESH:D045169
518 22276-22285 Disease denotes infection MESH:D007239
519 22830-22839 Disease denotes infection MESH:D007239
520 23303-23312 Disease denotes infection MESH:D007239
521 23544-23548 Disease denotes SARS MESH:D045169
522 23643-23648 Disease denotes edema MESH:D004487
523 23704-23715 Disease denotes lung injury MESH:D055370
524 23820-23829 Disease denotes infection MESH:D007239
525 23871-23886 Disease denotes viral infection MESH:D001102
527 23979-23983 Gene denotes ACE2 Gene:59272
552 24248-24252 Gene denotes ACE2 Gene:59272
553 24447-24451 Gene denotes ACE2 Gene:59272
554 24571-24575 Gene denotes ACE2 Gene:59272
555 24732-24736 Gene denotes ACE2 Gene:59272
556 24754-24758 Gene denotes ACE2 Gene:59272
557 24832-24836 Gene denotes ACE2 Gene:59272
558 24904-24908 Gene denotes ACE2 Gene:59272
559 25130-25134 Gene denotes ACE2 Gene:59272
560 25188-25192 Gene denotes ACE2 Gene:59272
561 25344-25348 Gene denotes ACE2 Gene:59272
562 24589-24590 Gene denotes S Gene:43740568
563 24285-24286 Gene denotes S Gene:43740568
564 24113-24124 Species denotes coronavirus Tax:11118
565 24298-24307 Species denotes 2019-nCoV Tax:2697049
566 24379-24389 Species denotes SARS virus Tax:694009
567 24491-24501 Species denotes SARS virus Tax:694009
568 24697-24706 Species denotes 2019-nCoV Tax:2697049
569 24781-24789 Species denotes patients Tax:9606
570 25230-25246 Species denotes SARS coronavirus Tax:694009
571 25376-25385 Species denotes 2019-nCoV Tax:2697049
572 25414-25422 Species denotes patients Tax:9606
573 25169-25174 Species denotes human Tax:9606
574 24172-24180 Disease denotes infected MESH:D007239
575 24584-24588 Disease denotes SARS MESH:D045169
615 25457-25461 Gene denotes ACE2 Gene:59272
616 25514-25518 Gene denotes ACE2 Gene:59272
617 25820-25824 Gene denotes ACE2 Gene:59272
618 25846-25850 Gene denotes ACE2 Gene:59272
619 25963-25967 Gene denotes ACE2 Gene:59272
620 26039-26053 Gene denotes angiotensin II Gene:183
621 26148-26152 Gene denotes ACE2 Gene:59272
622 26312-26316 Gene denotes ACE2 Gene:59272
623 26578-26584 Gene denotes Ang1-8 Gene:284
624 26821-26825 Gene denotes ACE2 Gene:59272
625 25477-25478 Gene denotes S Gene:43740568
626 25467-25476 Species denotes 2019-nCoV Tax:2697049
627 25604-25612 Species denotes patients Tax:9606
628 26177-26204 Species denotes respiratory syncytial virus Tax:12814
629 26212-26216 Species denotes H5N1 Tax:102793
630 26306-26311 Species denotes human Tax:9606
631 26398-26406 Species denotes patients Tax:9606
632 26868-26877 Species denotes 2019-nCoV Tax:2697049
633 26878-26886 Species denotes patients Tax:9606
634 26217-26226 Species denotes influenza Tax:11320
635 26644-26655 Species denotes respiratory Tax:12814
636 26318-26324 Chemical denotes rhACE2
637 26437-26443 Chemical denotes rhACE2
638 26701-26707 Chemical denotes rhACE2
639 25564-25573 Disease denotes pneumonia MESH:D011014
640 25618-25622 Disease denotes SARS MESH:D045169
641 25627-25646 Disease denotes 2019-nCoV infection MESH:C000657245
642 25655-25664 Disease denotes pneumonia MESH:D011014
643 25692-25707 Disease denotes pulmonary edema MESH:D011654
644 25712-25747 Disease denotes acute respiratory distress syndrome MESH:D012128
645 25749-25753 Disease denotes ARDS MESH:D012128
646 25793-25797 Disease denotes ARDS MESH:D012128
647 26008-26019 Disease denotes lung injury MESH:D055370
648 26169-26173 Disease denotes ARDS MESH:D012128
649 26230-26239 Disease denotes infection MESH:D007239
650 26375-26379 Disease denotes ARDS MESH:D012128
651 26383-26397 Disease denotes critically ill MESH:D016638
652 26766-26770 Disease denotes ARDS MESH:D012128
653 26860-26864 Disease denotes ARDS MESH:D012128
763 30382-30391 Species denotes 2019-nCoV Tax:2697049
673 26981-26985 Gene denotes ACE2 Gene:59272
674 27080-27084 Gene denotes ACE2 Gene:59272
937 35397-35401 Disease denotes ARDS MESH:D012128
675 27214-27218 Gene denotes ACE2 Gene:59272
676 27293-27297 Gene denotes ACE2 Gene:59272
677 27485-27489 Gene denotes ACE2 Gene:59272
678 27565-27569 Gene denotes ACE2 Gene:59272
679 27668-27672 Gene denotes ACE2 Gene:59272
680 27736-27740 Gene denotes ACE2 Gene:59272
681 27635-27636 Gene denotes S Gene:43740568
682 27521-27522 Gene denotes S Gene:43740568
683 26913-26922 Species denotes 2019-nCoV Tax:2697049
684 26923-26931 Species denotes patients Tax:9606
685 27005-27010 Species denotes human Tax:9606
686 27511-27520 Species denotes 2019-nCoV Tax:2697049
687 27625-27634 Species denotes 2019-nCoV Tax:2697049
688 27773-27783 Species denotes SARS virus Tax:694009
689 27802-27811 Species denotes 2019-nCoV Tax:2697049
690 27134-27138 Disease denotes SARS MESH:D045169
691 27423-27434 Disease denotes lung injury MESH:D055370
694 27865-27869 Gene denotes ACE2 Gene:59272
695 27909-27930 Species denotes 2019-nCoV coronavirus Tax:2697049
705 27965-27969 Gene denotes ACE2 Gene:59272
706 28097-28101 Gene denotes ACE2 Gene:59272
707 28147-28151 Gene denotes ACE2 Gene:59272
708 28187-28191 Gene denotes ACE2 Gene:59272
709 28243-28247 Gene denotes ACE2 Gene:59272
710 27991-27996 Species denotes human Tax:9606
711 28237-28242 Species denotes human Tax:9606
712 28304-28309 Species denotes human Tax:9606
713 28420-28425 Species denotes human Tax:9606
745 28729-28733 Gene denotes ACE2 Gene:70008
746 28829-28833 Gene denotes ACE2 Gene:70008
747 29129-29133 Gene denotes CD16 Gene:2214
748 29506-29510 Gene denotes ACE2 Gene:59272
749 29979-29983 Gene denotes ACE2 Gene:59272
750 30026-30030 Gene denotes ACE2 Gene:59272
751 30113-30117 Gene denotes ACE2 Gene:59272
752 30299-30303 Gene denotes ACE2 Gene:59272
753 30463-30467 Gene denotes ACE2 Gene:59272
754 28682-28690 Species denotes patients Tax:9606
755 28792-28796 Species denotes mice Tax:10090
756 29324-29329 Species denotes mouse Tax:10090
757 29721-29730 Species denotes 2019-nCoV Tax:2697049
758 29906-29928 Species denotes human coronavirus NL63 Tax:277944
759 29973-29978 Species denotes human Tax:9606
760 30081-30090 Species denotes 2019-nCoV Tax:2697049
761 30239-30249 Species denotes SARS virus Tax:694009
762 30293-30298 Species denotes human Tax:9606
764 29964-29968 Species denotes NL63 Tax:277944
765 30002-30006 Species denotes NL63 Tax:277944
766 28673-28681 Disease denotes infected MESH:D007239
767 28881-28893 Disease denotes hypertension MESH:D006973
768 29170-29178 Disease denotes infected MESH:D007239
769 29319-29323 Disease denotes SARS MESH:D045169
770 29397-29401 Disease denotes SARS MESH:D045169
771 29649-29658 Disease denotes infection MESH:D007239
772 29880-29884 Disease denotes SARS MESH:D045169
773 29991-29995 Disease denotes SARS MESH:D045169
774 30048-30052 Disease denotes SARS MESH:D045169
775 30332-30341 Disease denotes infection MESH:D007239
800 30665-30668 Gene denotes CD4 Gene:920
801 30675-30678 Gene denotes CD4 Gene:920
802 30806-30818 Gene denotes CD4 receptor Gene:920
803 30842-30847 Gene denotes gp120 Gene:3700
804 30886-30889 Gene denotes CD4 Gene:920
805 31108-31111 Gene denotes CD4 Gene:920
806 31205-31209 Gene denotes CCR5 Gene:1234
807 31001-31009 Species denotes patients Tax:9606
808 31325-31340 Species denotes rhesus macaques Tax:9544
809 31363-31398 Species denotes simian-human immunodeficiency virus Tax:57667
810 31432-31441 Species denotes 2019-nCoV Tax:2697049
811 31621-31630 Species denotes 2019-nCoV Tax:2697049
812 31645-31654 Species denotes 2019-nCoV Tax:2697049
813 31723-31734 Species denotes respiratory Tax:12814
814 30736-30739 Species denotes HIV Tax:12721
815 30918-30921 Species denotes HIV Tax:12721
816 31301-31304 Species denotes HIV Tax:12721
817 31424-31427 Species denotes HIV Tax:12721
818 31555-31558 Species denotes HIV Tax:12721
819 31784-31787 Species denotes HIV Tax:12721
820 30866-30878 Disease denotes infected HIV MESH:D015658
821 30943-30952 Disease denotes infection MESH:D007239
822 31766-31775 Disease denotes infection MESH:D007239
823 31802-31819 Disease denotes chronic infection MESH:D007239
851 31897-31901 Gene denotes ACE2 Gene:59272
852 31962-31966 Gene denotes ACE2 Gene:59272
853 32119-32123 Gene denotes ACE2 Gene:59272
854 32258-32262 Gene denotes ACE2 Gene:59272
855 32428-32432 Gene denotes ACE2 Gene:59272
856 32522-32526 Gene denotes ACE2 Gene:59272
857 32754-32758 Gene denotes ACE2 Gene:59272
858 32864-32868 Gene denotes ACE2 Gene:59272
859 32988-32992 Gene denotes ACE2 Gene:59272
860 33092-33096 Gene denotes ACE2 Gene:59272
861 33158-33162 Gene denotes ACE2 Gene:59272
862 33325-33336 Gene denotes Fc receptor
863 33338-33342 Gene denotes CD16 Gene:2214
864 33618-33622 Gene denotes ACE2 Gene:59272
865 32673-32674 Gene denotes S Gene:43740568
866 32301-32309 Species denotes patients Tax:9606
867 32337-32345 Species denotes patients Tax:9606
868 32404-32413 Species denotes 2019-nCoV Tax:2697049
869 32414-32422 Species denotes patients Tax:9606
870 32663-32672 Species denotes 2019-nCoV Tax:2697049
871 33298-33307 Species denotes 2019-nCoV Tax:2697049
872 32814-32823 Chemical denotes histidine MESH:D006639
873 32351-32362 Disease denotes lung injury MESH:D055370
874 32654-32658 Disease denotes SARS MESH:D045169
875 32958-32962 Disease denotes SARS MESH:D045169
876 33109-33120 Disease denotes lung injury MESH:D055370
877 33421-33425 Disease denotes MERS MESH:D018352
897 34090-34094 Gene denotes ACE2 Gene:59272
898 34155-34159 Gene denotes ACE2 Gene:59272
899 34277-34281 Gene denotes ACE2 Gene:59272
900 34494-34498 Gene denotes ACE2 Gene:59272
901 34772-34776 Gene denotes ACE2 Gene:59272
902 33718-33727 Species denotes 2019-nCoV Tax:2697049
903 33762-33770 Species denotes patients Tax:9606
904 33938-33946 Species denotes patients Tax:9606
905 34040-34049 Species denotes 2019-nCoV Tax:2697049
906 34267-34275 Species denotes patients Tax:9606
907 34637-34642 Species denotes yeast Tax:4932
908 34927-34935 Species denotes patients Tax:9606
909 33805-33813 Disease denotes infected MESH:D007239
910 33929-33937 Disease denotes infected MESH:D007239
911 34007-34012 Disease denotes death MESH:D003643
912 34160-34170 Disease denotes deficiency MESH:D007153
913 34175-34186 Disease denotes lung injury MESH:D055370
914 34258-34266 Disease denotes infected MESH:D007239
915 34624-34627 CellLine denotes CHO CVCL:0213
928 34960-34964 Gene denotes ACE2 Gene:59272
929 35245-35249 Gene denotes ACE2 Gene:59272
930 35572-35576 Gene denotes ACE2 Gene:59272
931 35001-35009 Species denotes patients Tax:9606
932 35344-35353 Species denotes 2019-nCoV Tax:2697049
933 35426-35433 Species denotes patient Tax:9606
934 35500-35507 Species denotes patient Tax:9606
935 34980-34989 Disease denotes infection MESH:D007239
936 35049-35054 Disease denotes death MESH:D003643
938 35434-35443 Disease denotes mortality MESH:D003643
939 35542-35550 Disease denotes infected MESH:D007239
951 36300-36304 Gene denotes ACE2 Gene:59272
952 36467-36471 Gene denotes ACE2 Gene:59272
953 35922-35923 Gene denotes S Gene:43740568
954 35804-35813 Species denotes 2019-nCoV Tax:2697049
955 36272-36281 Species denotes 2019-nCoV Tax:2697049
956 36414-36423 Species denotes 2019-nCoV Tax:2697049
957 36571-36593 Species denotes human coronavirus NL63 Tax:277944
958 36813-36821 Species denotes patients Tax:9606
959 36376-36385 Disease denotes infection MESH:D007239
960 36559-36563 Disease denotes SARS MESH:D045169
961 36840-36848 Disease denotes infected MESH:D007239
969 36974-36978 Gene denotes ACE2 Gene:59272
970 37058-37062 Gene denotes IgG3 Gene:3502
971 37203-37207 Gene denotes ACE2 Gene:59272
972 37235-37239 Gene denotes ACE2 Gene:59272
973 37602-37606 Gene denotes ACE2 Gene:59272
974 36935-36944 Species denotes 2019-nCoV Tax:2697049
975 37028-37033 Species denotes human Tax:9606
991 37732-37736 Gene denotes ACE2 Gene:59272
992 37944-37948 Gene denotes ACE2 Gene:59272
993 38362-38366 Gene denotes DPP4 Gene:1803
994 38429-38433 Gene denotes DPP4 Gene:1803
995 38576-38580 Gene denotes ACE2 Gene:59272
996 37842-37851 Species denotes 2019-nCoV Tax:2697049
997 37861-37876 Species denotes new coronavirus Tax:2697049
998 37979-37992 Species denotes coronaviruses Tax:11118
999 38465-38478 Species denotes coronaviruses Tax:11118
1000 37833-37837 Disease denotes SARS MESH:D045169
1001 37897-37905 Disease denotes zoonotic MESH:D015047
1002 38230-38238 Disease denotes zoonotic MESH:D015047
1003 38395-38399 Disease denotes MERS MESH:D018352
1004 38616-38620 Disease denotes ARDS MESH:D012128
1005 38663-38680 Disease denotes acute lung injury MESH:D055371
1010 38747-38751 Gene denotes ACE2 Gene:59272
1011 39023-39032 Species denotes 2019-nCoV Tax:2697049
1012 38751-38754 Chemical denotes -Fc
1013 38855-38874 Disease denotes 2019-nCoV infection MESH:C000657245

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 17686-17697 https://glytoucan.org/Structures/Glycans/G81533KY denotes sialic acid

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T569 25806-25811 NCBITaxon:10239 denotes viral
T568 25820-25824 G_3;PG_10;PR:000003622 denotes ACE2
T567 25846-25850 G_3;PG_10;PR:000003622 denotes ACE2
T566 25869-25879 GO:0010467 denotes expression
T565 25911-25920 PG_1 denotes S protein
T564 25963-25967 G_3;PG_10;PR:000003622 denotes ACE2
T563 26008-26012 UBERON:0002048 denotes lung
T562 26039-26053 PR:000036009;DG_37 denotes angiotensin II
T561 26100-26114 DG_37;PR:000001251 denotes angiotensin II
T560 26115-26131 PR:000001251 denotes type 1a receptor
T559 26148-26152 G_3;PG_10;PR:000003622 denotes ACE2
T558 26177-26188 UBERON:0001004;NCBITaxon:12814 denotes respiratory
T557 26189-26198 NCBITaxon:12814 denotes syncytial
T556 26199-26204 NCBITaxon:10239 denotes virus
T555 26306-26311 SP_6;NCBITaxon:9606;PG_10 denotes human
T554 26312-26316 PG_10;PR:000003622 denotes ACE2
T553 26491-26512 UBERON:0004535 denotes cardiovascular system
T552 26578-26582 PR:000004020 denotes Ang1
T551 26630-26640 GO:0065007 denotes modulation
T550 26644-26655 UBERON:0001004 denotes respiratory
T549 26794-26800 NCBITaxon:33208 denotes animal
T548 26821-26825 G_3;PG_10;PR:000003622 denotes ACE2
T547 26868-26877 SP_7 denotes 2019-nCoV
T546 26913-26922 SP_7 denotes 2019-nCoV
T545 26953-26966 GO:0005576 denotes extracellular
T544 26967-26973 SO:0000417 denotes domain
T543 26981-26985 G_3;PG_10;PR:000003622 denotes ACE2
T542 27005-27010 SP_6;NCBITaxon:9606 denotes human
T541 27011-27025 GO:0019814 denotes immunoglobulin
T540 27031-27037 SO:0000417 denotes domain
T539 27080-27084 G_3;PG_10;PR:000003622 denotes ACE2
T538 27134-27138 SP_10;PG_9 denotes SARS
T537 27139-27140 PG_9;PG_1 denotes S
T536 27141-27148 PG_1 denotes protein
T535 27193-27199 SO:0000417 denotes domain
T534 27214-27218 G_3;PG_10;PR:000003622 denotes ACE2
T533 27279-27292 GO:0005576 denotes extracellular
T532 27293-27297 G_3;PG_10 denotes ACE2
T531 27298-27304 SO:0000417 denotes domain
T530 27327-27336 PG_1 denotes S protein
T529 27423-27427 UBERON:0002048 denotes lung
T528 27485-27489 G_3;PG_10 denotes ACE2
T527 27490-27496 SO:0000417 denotes domain
T526 27511-27520 SP_7 denotes 2019-nCoV
T525 27521-27530 PG_1 denotes S protein
T524 27565-27569 G_3;PG_10;PR:000003622 denotes ACE2
T523 27625-27634 SP_7 denotes 2019-nCoV
T522 27635-27644 PG_1 denotes S protein
T521 27668-27672 G_3;PG_10;PR:000003622 denotes ACE2
T520 27736-27740 G_3;PG_10;PR:000003622 denotes ACE2
T519 27749-27756 SO:0000417 denotes domains
T518 27773-27777 SP_10;NCBITaxon:10633 denotes SARS
T517 27778-27783 NCBITaxon:10239 denotes virus
T516 27802-27811 SP_7 denotes 2019-nCoV
T515 28518-28524 SO:0000417 denotes domain
T514 28563-28567 CHEBI:23888;CHEBI:23888 denotes drug
T513 28631-28635 CHEBI:23888;CHEBI:23888 denotes drug
T512 28729-28733 G_3;PG_10;PR:000003622 denotes ACE2
T511 28792-28796 NCBITaxon:10088 denotes mice
T510 28829-28833 G_3;PG_10;PR:000003622 denotes ACE2
T509 28966-28974 CHEBI:35224;CHEBI:35224 denotes effector
T508 28995-29001 SO:0000417 denotes domain
T507 29028-29036 CHEBI:36357;CHEBI:36357 denotes molecule
T506 29062-29071 GO:0030425;CL:0000451 denotes dendritic
T505 29072-29077 CL:0000451 denotes cells
T504 29079-29090 CL:0000235 denotes macrophages
T503 29096-29116 CL:0000623 denotes natural killer cells
T502 29129-29133 PR:000001483 denotes CD16
T501 29151-29156 NCBITaxon:10239 denotes viral
T500 29246-29252 UBERON:0002405;GO:0006955 denotes immune
T499 29253-29261 GO:0006955 denotes response
T498 29285-29290 NCBITaxon:10239 denotes virus
T497 29319-29323 SP_10 denotes SARS
T496 29324-29329 NCBITaxon:10088 denotes mouse
T495 29354-29364 GO:0042571 denotes antibodies
T494 29397-29401 SP_10 denotes SARS
T493 29406-29419 GO:0001775 denotes activation of
T492 29420-29430 GO:0006909;CL:0000234 denotes phagocytic
T491 29431-29436 CL:0000234 denotes cells
T490 29449-29459 GO:0042571 denotes antibodies
T489 29477-29482 NCBITaxon:10239 denotes virus
T488 29506-29510 G_3;PG_10;PR:000003622 denotes ACE2
T487 29596-29604 GO:0042571 denotes antibody
T486 29721-29730 SP_7 denotes 2019-nCoV
T485 29863-29876 BV_19 denotes pathogenicity
T484 29880-29884 SP_10 denotes SARS
T483 29906-29911 SP_6;NCBITaxon:9606 denotes human
T482 29912-29923 NCBITaxon:11118 denotes coronavirus
T481 29973-29978 SP_6;NCBITaxon:9606;PG_10 denotes human
T480 29979-29983 PG_10;PR:000003622 denotes ACE2
T479 29991-29995 SP_10 denotes SARS
T478 30007-30016 PG_1 denotes S protein
T477 30026-30030 G_3;PG_10;PR:000003622 denotes ACE2
T476 30048-30052 SP_10;PG_9 denotes SARS
T475 30053-30054 PG_9;PG_1 denotes S
T474 30055-30062 PG_1 denotes protein
T473 30081-30090 SP_7 denotes 2019-nCoV
T472 30113-30117 G_3;PG_10;PR:000003622 denotes ACE2
T471 30197-30202 NCBITaxon:10239 denotes virus
T470 30239-30243 SP_10;NCBITaxon:10633 denotes SARS
T469 30244-30249 NCBITaxon:10239 denotes virus
T468 30293-30298 SP_6;NCBITaxon:9606;PG_10 denotes human
T467 30299-30303 PG_10;PR:000003622 denotes ACE2
T466 30382-30391 SP_7 denotes 2019-nCoV
T465 30463-30467 G_3;PG_10;PR:000003622 denotes ACE2
T464 30665-30668 PR:000001004 denotes CD4
T463 30675-30678 PR:000001004 denotes CD4
T462 30679-30682 GO:0071735 denotes IgG
T461 30791-30798 SO:0000417 denotes domains
T460 30806-30809 PR:000001004 denotes CD4
T459 30842-30847 PR:000003229 denotes gp120
T458 30855-30865 GO:0009986 denotes surface of
T457 30886-30889 PR:000001004 denotes CD4
T456 30890-30893 GO:0071735 denotes IgG
T455 31108-31111 PR:000001004 denotes CD4
T454 31112-31115 GO:0071735 denotes IgG
T453 31205-31209 PR:000001201 denotes CCR5
T452 31305-31313 SO:0001060 denotes isolates
T451 31325-31331 NCBITaxon:9654 denotes rhesus
T450 31332-31340 NCBITaxon:9539 denotes macaques
T449 31363-31369 NCBITaxon:10633 denotes simian
T448 31369-31370 NCBITaxon:57667 denotes -
T447 31370-31375 SP_6;NCBITaxon:9606 denotes human
T446 31393-31398 NCBITaxon:10633 denotes virus
T445 31432-31441 SP_7 denotes 2019-nCoV
T444 31461-31468 NCBITaxon:10239 denotes viruses
T443 31621-31630 SP_7 denotes 2019-nCoV
T442 31645-31654 SP_7 denotes 2019-nCoV
T441 31723-31734 NCBITaxon:11886;UBERON:0001004 denotes respiratory
T440 31735-31740 NCBITaxon:10239 denotes virus
T439 31897-31901 G_3;PG_10;PR:000003622 denotes ACE2
T438 31948-31961 GO:0005576 denotes extracellular
T437 31962-31966 G_3;PG_10;PR:000003622 denotes ACE2
T436 32062-32068 SO:0000417 denotes domain
T435 32105-32118 GO:0005576 denotes extracellular
T434 32119-32123 G_3;PG_10;PR:000003622 denotes ACE2
T433 32136-32144 GO:0032941 denotes secreted
T432 32148-32155 UBERON:0000479 denotes tissues
T431 32184-32197 GO:0005576 denotes extracellular
T430 32198-32204 SO:0000417 denotes domain
T429 32258-32262 G_3;PG_10;PR:000003622 denotes ACE2
T428 32351-32355 UBERON:0002048 denotes lung
T427 32404-32413 SP_7 denotes 2019-nCoV
T426 32428-32432 G_3;PG_10;PR:000003622 denotes ACE2
T425 32522-32526 G_3;PG_10;PR:000003622 denotes ACE2
T424 32654-32658 SP_10 denotes SARS
T423 32663-32672 SP_7 denotes 2019-nCoV
T422 32673-32682 PG_1 denotes S protein
T421 32754-32758 G_3;PG_10;PR:000003622 denotes ACE2
T404 17059-17065 CHEBI:38867;CHEBI:38867 denotes agents
T403 17079-17083 G_3;PG_10;PR:000003622 denotes ACE2
T402 17183-17187 G_3;PG_10;PR:000003622 denotes ACE2
T401 17229-17233 G_3;PG_10;PR:000003622 denotes ACE2
T400 17324-17329 CHEBI:52217;CHEBI:52217 denotes agent
T399 17345-17350 NCBITaxon:10239 denotes virus
T398 17556-17565 NCBITaxon:7719 denotes influenza
T397 17566-17571 NCBITaxon:10239 denotes virus
T396 17619-17627 GO:0042571 denotes antibody
T395 17686-17697 CHEBI:26667;CHEBI:26667 denotes sialic acid
T394 17710-17717 GO:0009986 denotes surface
T393 17793-17797 G_3;PG_10;PR:000003622 denotes ACE2
T392 17845-17851 SO:0000417 denotes domain
T391 17867-17871 SP_10;PG_9 denotes SARS
T390 17872-17873 PG_9;PG_1 denotes S
T389 17874-17881 PG_1 denotes protein
T388 17916-17922 SO:0000417 denotes domain
T387 17938-17942 G_3;PG_10;PR:000003622 denotes ACE2
T386 17992-17998 SO:0000417 denotes domain
T385 18074-18078 SP_10 denotes SARS
T384 18129-18133 SP_10 denotes SARS
T383 18188-18192 G_3;PG_10;PR:000003622 denotes ACE2
T382 18307-18316 SP_7 denotes 2019-nCoV
T381 18385-18389 SP_10 denotes SARS
T380 18394-18403 SP_7 denotes 2019-nCoV
T379 18419-18431 SO:0000409 denotes binding site
T378 18435-18439 G_3;PG_10;PR:000003622 denotes ACE2
T377 18482-18486 G_3;PG_10;PR:000003622 denotes ACE2
T376 18487-18500 SO:0000409 denotes binding sites
T375 18504-18508 SP_10 denotes SARS
T374 18518-18529 NCBITaxon:11118 denotes coronavirus
T373 18610-18620 GO:0042571 denotes antibodies
T372 18671-18678 UBERON:0000479 denotes tissues
T371 18707-18712 NCBITaxon:10239;GO:0035376 denotes viral
T370 18713-18718 GO:0035376 denotes entry
T369 18856-18864 NCBITaxon:2 denotes bacteria
T368 18927-18936 NCBITaxon:2 denotes bacterial
T367 19259-19265 SO:0000417 denotes domain
T366 19271-19275 SP_9 denotes MERS
T365 19281-19285 SP_9 denotes MERS
T364 19334-19339 NCBITaxon:10239;GO:0006260 denotes viral
T363 19400-19406 UBERON:0002405;GO:0006955 denotes immune
T362 19407-19415 GO:0006955 denotes response
T361 19438-19443 NCBITaxon:10239 denotes viral
T360 19444-19450 SO:0000417 denotes domain
T359 19454-19458 NCBITaxon:10088 denotes mice
T358 19565-19571 SO:0000417 denotes domain
T357 20591-20599 GO:0042571 denotes antibody
T356 20619-20623 G_3;PG_10;PR:000003622 denotes ACE2
T355 20652-20661 SP_7 denotes 2019-nCoV
T354 20730-20734 SP_10 denotes SARS
T353 20745-20756 GO:0006260 denotes replication
T352 20785-20789 G_3;PG_10;PR:000003622 denotes ACE2
T351 20790-20798 GO:0042571 denotes antibody
T350 20857-20867 GO:0042571 denotes antibodies
T349 20987-20992 NCBITaxon:10239 denotes viral
T348 21008-21012 G_3;PG_10;PR:000003622 denotes ACE2
T347 21021-21029 GO:0042571 denotes antibody
T346 21094-21103 PG_1 denotes S protein
T345 21187-21191 G_3;PG_10;PR:000003622 denotes ACE2
T344 21192-21200 GO:0042571 denotes antibody
T343 21215-21223 CHEBI:35224;CHEBI:35224 denotes effector
T342 21271-21277 SO:0000417 denotes domain
T341 21338-21345 UBERON:0000479 denotes tissues
T340 21346-21356 GO:0010467 denotes expressing
T339 21357-21361 G_3;PG_10;PR:000003622 denotes ACE2
T338 21418-21424 SO:0000417 denotes domain
T337 21491-21497 SO:0000417 denotes domain
T336 21534-21543 NCBITaxon:40674 denotes mammalian
T335 21544-21559 GO:0006412 denotes cell production
T334 21658-21662 CHEBI:23888;CHEBI:23888 denotes drug
T333 21796-21800 G_3;PG_10;PR:000003622 denotes ACE2
T332 21820-21827 SO:0000417 denotes domains
T331 21904-21912 NCBITaxon:2 denotes bacteria
T330 21981-21988 UBERON:0000479 denotes tissues
T329 22037-22046 CHEBI:36357;CHEBI:36357 denotes molecules
T328 22062-22068 SO:0000417 denotes domain
T327 22136-22140 SP_10 denotes SARS
T326 22188-22194 UBERON:0002405;GO:0006955 denotes immune
T325 22195-22203 GO:0006955 denotes response
T324 22211-22215 SP_10 denotes SARS
T323 22296-22305 SP_7 denotes 2019-nCoV
T322 22359-22365 UBERON:0002405;GO:0006955 denotes immune
T321 22366-22374 GO:0006955 denotes response
T320 22384-22391 NCBITaxon:10239 denotes viruses
T319 22465-22474 SP_7 denotes 2019-nCoV
T318 22488-22494 UBERON:0002405;GO:0006955 denotes immune
T317 22495-22503 GO:0006955 denotes response
T316 22671-22675 G_3;PG_10;PR:000003622 denotes ACE2
T315 22715-22721 UBERON:0000062 denotes organs
T314 22762-22766 G_3;PG_10;PR:000003622 denotes ACE2
T313 22855-22859 G_3;PG_10;PR:000003622 denotes ACE2
T312 22902-22906 UBERON:0002048 denotes lung
T311 22911-22927 UBERON:0001555 denotes gastrointestinal
T310 22928-22934 UBERON:0000062 denotes organs
T309 22946-22954 CL:0002139 denotes vascular
T308 22955-22966 CL:0002139;UBERON:0001986 denotes endothelial
T307 22967-22972 CL:0002139 denotes cells
T306 22985-22992 UBERON:0000479 denotes tissues
T305 23081-23085 G_3;PG_10;PR:000003622 denotes ACE2
T304 23102-23114 GO:0009986 denotes cell surface
T303 23267-23271 G_3;PG_10;PR:000003622 denotes ACE2
T302 23320-23325 UBERON:0000170 denotes lungs
T301 23355-23360 UBERON:0000170 denotes lungs
T300 23425-23429 G_3;PG_10;PR:000003622 denotes ACE2
T299 23466-23470 UBERON:0002048 denotes lung
T298 23544-23548 SP_10 denotes SARS
T297 23559-23565 SO:0000417 denotes domain
T296 23572-23576 G_3;PG_10;PR:000003622 denotes ACE2
T295 23580-23586 NCBITaxon:39107 denotes murine
T294 23587-23591 UBERON:0002048 denotes lung
T293 23592-23598 UBERON:0000479 denotes tissue
T292 23634-23642 UBERON:0003215 denotes alveolar
T291 23653-23657 G_3;PG_10;PR:000003622 denotes ACE2
T290 23704-23708 UBERON:0002048 denotes lung
T289 23758-23762 G_3;PG_10;PR:000003622 denotes ACE2
T288 23871-23876 NCBITaxon:10239 denotes viral
T287 15255-15264 SP_7 denotes 2019-nCoV
T286 15316-15321 NCBITaxon:10239 denotes virus
T285 15361-15371 GO:0042571 denotes antibodies
T284 15466-15476 GO:0042571 denotes antibodies
T283 15534-15542 GO:0042571 denotes antibody
T282 15599-15602 BV_22 denotes RNA
T281 15603-15608 BV_22;NCBITaxon:10239 denotes virus
T280 15647-15655 CHEBI:60004;CHEBI:60004 denotes cocktail
T279 15656-15664 GO:0042571 denotes antibody
T278 15895-15900 NCBITaxon:10239 denotes viral
T277 15901-15913 CHEBI:17089;BV_11;CHEBI:17089 denotes glycoprotein
T276 15999-16004 NCBITaxon:10239 denotes viral
T275 16029-16041 GO:0009986 denotes cell surface
T274 16064-16069 NCBITaxon:10239 denotes virus
T273 16175-16180 NCBITaxon:10239 denotes viral
T272 16253-16262 SP_7 denotes 2019-nCoV
T271 16272-16303 PG_10;PR:000003622 denotes angiotensin-converting enzyme 2
T270 16305-16309 G_3;PG_10;PR:000003622 denotes ACE2
T269 16380-16384 SP_10 denotes SARS
T268 16385-16396 NCBITaxon:11118 denotes coronavirus
T267 16425-16432 NCBITaxon:10239 denotes viruses
T266 16438-16449 NCBITaxon:11118 denotes coronavirus
T265 16459-16463 G_3;PG_10;PR:000003622 denotes ACE2
T264 16476-16485 PG_1 denotes S protein
T263 16513-16522 GO:0061025 denotes fusion of
T262 16527-16532 NCBITaxon:10239;GO:0036338 denotes viral
T261 16533-16541 GO:0036338 denotes membrane
T260 16546-16559 GO:0005886 denotes cell membrane
T259 16590-16593 BV_22 denotes RNA
T258 16594-16599 BV_22;NCBITaxon:10239 denotes virus
T257 16605-16614 GO:0006260 denotes replicate
T256 16619-16625 SO:0001026 denotes genome
T255 16688-16696 GO:0046903 denotes secreted
T254 16739-16743 SP_10 denotes SARS
T253 16748-16757 SP_7 denotes 2019-nCoV
T252 16764-16768 G_3;PG_10;PR:000003622 denotes ACE2
T251 16846-16850 SP_10 denotes SARS
T250 16876-16885 SP_7 denotes 2019-nCoV
T249 16900-16904 SP_10 denotes SARS
T248 17036-17040 SP_10 denotes SARS
T247 13240-13248 GO:0042571 denotes antibody
T246 13389-13394 UBERON:0001977 denotes serum
T245 13435-13440 NCBITaxon:10239 denotes virus
T244 13463-13471 GO:0006936 denotes contract
T243 13476-13481 NCBITaxon:10239 denotes virus
T242 13523-13528 NCBITaxon:10239 denotes viral
T241 13565-13573 GO:0042571 denotes antibody
T240 13574-13580 UBERON:0002405;GO:0006955 denotes immune
T239 13581-13589 GO:0006955 denotes response
T238 13603-13608 NCBITaxon:10239 denotes viral
T237 13609-13617 CHEBI:59132;CHEBI:59132 denotes antigens
T236 13621-13630 SP_7 denotes 2019-nCoV
T235 13657-13667 GO:0042571 denotes antibodies
T234 13695-13700 NCBITaxon:10239 denotes virus
T233 13794-13803 SP_7 denotes 2019-nCoV
T232 13804-13814 GO:0042571 denotes antibodies
T231 13862-13871 SP_7 denotes 2019-nCoV
T230 13890-13896 UBERON:0001969 denotes plasma
T229 13912-13918 UBERON:0001969 denotes plasma
T228 13975-13981 UBERON:0001969 denotes plasma
T227 14035-14041 UBERON:0001969 denotes plasma
T226 14265-14270 UBERON:0001977 denotes serum
T225 14484-14492 UBERON:0001977 denotes antisera
T224 14497-14506 SP_7 denotes 2019-nCoV
T223 14532-14540 UBERON:0001977 denotes antisera
T222 14804-14810 UBERON:0001969 denotes plasma
T221 14856-14860 UBERON:0001977 denotes sera
T220 15038-15042 UBERON:0001977 denotes sera
T219 15140-15151 GO:0065007 denotes controlling
T218 11585-11591 CHEBI:36357;CHEBI:36357 denotes agents
T217 11601-11610 SP_7 denotes 2019-nCoV
T216 11635-11643 CHEBI:36357;CHEBI:36357 denotes molecule
T215 11644-11649 CHEBI:23888;CHEBI:23888 denotes drugs
T214 11694-11699 NCBITaxon:10239 denotes viral
T213 11700-11704 UBERON:0000104 denotes life
T212 11734-11745 GO:0006260 denotes replication
T211 11784-11789 NCBITaxon:10239 denotes viral
T210 11818-11828 CHEBI:37670;CHEBI:37670 denotes inhibitors
T209 11865-11870 SP_6;NCBITaxon:9606 denotes human
T208 11888-11893 NCBITaxon:10376 denotes virus
T207 11904-11913 NCBITaxon:5690 denotes hepatitis
T206 11914-11921 NCBITaxon:10376 denotes C virus
T205 12088-12093 NCBITaxon:10239 denotes viral
T204 12183-12188 NCBITaxon:10376 denotes Ebola
T203 12228-12236 CHEBI:36357;CHEBI:36357 denotes molecule
T202 12237-12242 CHEBI:23888;CHEBI:23888 denotes drugs
T201 12326-12335 SP_7 denotes 2019-nCoV
T200 12400-12409 CHEBI:31781;DG_23;CHEBI:31781 denotes lopinavir
T199 12414-12423 DG_30 denotes ritonavir
T198 12448-12458 CHEBI:35660;CHEBI:35660 denotes inhibitors
T197 12496-12505 SP_7 denotes 2019-nCoV
T196 12551-12555 SP_10 denotes SARS
T195 12676-12685 SP_7 denotes 2019-nCoV
T194 12703-12707 CHEBI:23888;CHEBI:23888 denotes drug
T193 12750-12755 NCBITaxon:10239 denotes virus
T192 12836-12846 DG_28 denotes remdesivir
T191 12874-12879 NCBITaxon:10239 denotes viral
T190 12922-12926 SP_9 denotes MERS
T189 12930-12935 NCBITaxon:10088 denotes mouse
T188 12992-12996 CHEBI:23888;CHEBI:23888 denotes drug
T187 13021-13034 NCBITaxon:11118 denotes coronaviruses
T186 13150-13159 SP_7 denotes 2019-nCoV
T185 13214-13218 CHEBI:23888;CHEBI:23888 denotes drug
T184 9667-9676 SP_7 denotes 2019-nCoV
T183 9681-9687 SO:0001026 denotes genome
T182 9709-9716 GO:0009986 denotes surface
T181 9729-9738 SP_7 denotes 2019-nCoV
T180 9770-9776 SO:0001026 denotes genome
T179 9810-9816 SO:0001026 denotes genome
T178 9829-9838 SP_7 denotes 2019-nCoV
T177 9947-9968 SO:0000646 denotes small interfering RNA
T176 9970-9975 SO:0000646 denotes siRNA
T175 9980-9989 SO:0000077 denotes antisense
T174 10027-10032 NCBITaxon:10239 denotes virus
T173 10054-10060 SO:0001026 denotes genome
T172 10147-10154 SO:0000417 denotes domains
T171 10248-10253 SO:0000646 denotes siRNA
T170 10274-10279 NCBITaxon:10239 denotes viral
T169 10338-10344 SO:0001026 denotes genome
T168 10345-10353 SO:0000853 denotes homology
T167 10357-10366 SP_7 denotes 2019-nCoV
T166 10374-10384 NCBITaxon:10633 denotes SARS virus
T165 10534-10539 UBERON:0000170 denotes lungs
T164 10596-10601 CHEBI:18059;CHEBI:18059 denotes lipid
T757 27865-27869 G_3;PG_10;PR:000003622 denotes ACE2
T756 27909-27918 SP_7 denotes 2019-nCoV
T755 27919-27930 NCBITaxon:11118 denotes coronavirus
T754 27941-27954 GO:0005576 denotes extracellular
T753 27955-27961 SO:0000417 denotes domain
T752 27965-27969 G_3;PG_10;PR:000003622 denotes ACE2
T751 27991-27996 SP_6;NCBITaxon:9606 denotes human
T750 27997-28011 GO:0019814 denotes immunoglobulin
T749 28015-28021 SO:0000417 denotes domain
T748 28058-28064 SO:0000417 denotes domain
T747 28077-28089 GO:0046983 denotes dimerization
T746 28097-28101 G_3;PG_10 denotes ACE2
T745 28102-28109 SO:0000417 denotes domains
T744 28147-28151 G_3;PG_10;PR:000003622 denotes ACE2
T743 28187-28191 G_3;PG_10 denotes ACE2
T742 28192-28198 SO:0000417 denotes domain
T741 28237-28242 SP_6;NCBITaxon:9606;PG_10 denotes human
T740 28243-28247 PG_10;PR:000003622 denotes ACE2
T739 28304-28309 SP_6;NCBITaxon:9606 denotes human
T738 28310-28324 GO:0019814 denotes immunoglobulin
T737 28420-28425 SP_6;NCBITaxon:9606 denotes human
T736 28426-28438 CHEBI:60816;CHEBI:60816 denotes immunoglobin
T735 19662-19668 CHEBI:52217;CHEBI:52217 denotes agents
T734 19697-19706 SP_7 denotes 2019-nCoV
T733 19742-19752 GO:0010467 denotes expressing
T732 19753-19757 G_3;PG_10;PR:000003622 denotes ACE2
T731 19766-19770 UBERON:0002048 denotes lung
T730 19775-19791 UBERON:0001555 denotes gastrointestinal
T729 19792-19799 UBERON:0000479 denotes tissues
T728 19807-19812 SP_6;NCBITaxon:9606 denotes human
T727 19850-19857 GO:0009986 denotes surface
T726 19865-19876 NCBITaxon:11118 denotes coronavirus
T725 19886-19890 G_3;PG_10;PR:000003622 denotes ACE2
T724 19921-19931 GO:0035376 denotes cell entry
T723 20049-20055 SO:0000417 denotes domain
T722 20088-20092 SP_10 denotes SARS
T721 20096-20105 SP_7 denotes 2019-nCoV
T720 20145-20149 G_3;PG_10;PR:000003622 denotes ACE2
T719 20200-20208 GO:0042571 denotes antibody
T718 20212-20218 SO:0000984 denotes single
T717 20225-20233 GO:0042571 denotes antibody
T716 20280-20284 G_3;PG_10;PR:000003622 denotes ACE2
T715 20343-20354 NCBITaxon:11118 denotes coronavirus
T714 20385-20389 G_3;PG_10;PR:000003622 denotes ACE2
T713 20390-20403 GO:0005576 denotes extracellular
T712 20404-20410 SO:0000417 denotes domain
T711 20451-20457 SO:0000417 denotes domain
T710 20467-20471 G_3;PG_10;PR:000003622 denotes ACE2
T709 20528-20532 G_3;PG_10;PR:000003622 denotes ACE2
T708 33718-33727 SP_7 denotes 2019-nCoV
T707 33782-33793 NCBITaxon:1 denotes individuals
T706 33949-33959 CHEBI:23888;CHEBI:23888 denotes medication
T705 34007-34012 GO:0016265 denotes death
T704 34040-34049 SP_7 denotes 2019-nCoV
T703 34090-34094 G_3;PG_10;PR:000003622 denotes ACE2
T702 34155-34159 G_3;PG_10;PR:000003622 denotes ACE2
T701 34175-34179 UBERON:0002048 denotes lung
T700 34192-34197 NCBITaxon:10239 denotes virus
T699 34222-34228 UBERON:0002405 denotes immune
T698 34229-34237 CHEBI:35224;CHEBI:35224 denotes effector
T697 34277-34281 G_3;PG_10;PR:000003622 denotes ACE2
T696 34494-34498 G_3;PG_10;PR:000003622 denotes ACE2
T695 34594-34601 BV_20 denotes protein
T694 34602-34612 BV_20;GO:0010467 denotes expression
T693 34629-34635 NCBITaxon:6960 denotes insect
T692 34726-34730 SO:0000704 denotes Gene
T691 34772-34776 G_3;PG_10;PR:000003622 denotes ACE2
T690 34960-34964 G_3;PG_10;PR:000003622 denotes ACE2
T689 35049-35054 GO:0016265 denotes death
T688 35180-35191 NCBITaxon:1 denotes individuals
T687 35225-35230 NCBITaxon:10239 denotes virus
T686 35245-35249 G_3;PG_10;PR:000003622 denotes ACE2
T685 35286-35294 GO:0042571 denotes antibody
T684 35344-35353 SP_7 denotes 2019-nCoV
T683 35508-35512 UBERON:0001977 denotes sera
T682 35551-35562 NCBITaxon:1 denotes individuals
T681 35572-35576 G_3;PG_10;PR:000003622 denotes ACE2
T680 35602-35607 NCBITaxon:10239 denotes viral
T679 35665-35675 GO:0042571 denotes antibodies
T678 35804-35813 SP_7 denotes 2019-nCoV
T677 35890-35900 GO:0042571 denotes antibodies
T676 35922-35931 PG_1 denotes S protein
T675 36072-36086 BV_15 denotes immunogenicity
T674 36088-36095 CHEBI:59132;CHEBI:59132 denotes antigen
T673 36110-36118 CHEBI:60809;CHEBI:60809 denotes adjuvant
T672 36140-36148 GO:0042571 denotes antibody
T671 36166-36171 NCBITaxon:10239 denotes virus
T670 36272-36281 SP_7 denotes 2019-nCoV
T669 36300-36304 G_3;PG_10;PR:000003622 denotes ACE2
T668 36414-36423 SP_7 denotes 2019-nCoV
T667 36467-36471 G_3;PG_10;PR:000003622 denotes ACE2
T666 36559-36563 SP_10 denotes SARS
T665 36571-36576 SP_6;NCBITaxon:9606 denotes human
T664 36577-36588 NCBITaxon:11118 denotes coronavirus
T663 36700-36706 SO:0000440 denotes vector
T662 36720-36725 NCBITaxon:10239 denotes viral
T661 36726-36732 SO:0000440 denotes vector
T660 36858-36863 NCBITaxon:10239 denotes virus
T659 36935-36944 SP_7 denotes 2019-nCoV
T658 36974-36978 G_3;PG_10;PR:000003622 denotes ACE2
T657 37028-37033 SP_6;NCBITaxon:9606 denotes human
T656 37037-37044 SO:0000417 denotes domains
T655 37203-37207 G_3;PG_10;PR:000003622 denotes ACE2
T654 37235-37239 G_3;PG_10;PR:000003622 denotes ACE2
T653 37297-37301 GO:0006412;SO:0000704 denotes gene
T652 37302-37311 GO:0071897 denotes synthesis
T651 37361-37365 SO:0000704 denotes gene
T650 37393-37400 BV_20 denotes protein
T649 37401-37411 BV_20;GO:0010467 denotes expression
T648 37574-37584 GO:0042571 denotes antibodies
T647 37602-37606 G_3;PG_10;PR:000003622 denotes ACE2
T646 37647-37655 GO:0042571 denotes antibody
T645 37732-37736 G_3;PG_10;PR:000003622 denotes ACE2
T644 37794-37798 CHEBI:23888;CHEBI:23888 denotes drug
T643 37833-37837 SP_10 denotes SARS
T642 37842-37851 SP_7 denotes 2019-nCoV
T641 37865-37876 NCBITaxon:11118 denotes coronavirus
T640 37944-37948 G_3;PG_10;PR:000003622 denotes ACE2
T639 37979-37992 NCBITaxon:11118 denotes coronaviruses
T638 37998-38007 GO:0006260 denotes replicate
T637 38011-38018 NCBITaxon:33208 denotes animals
T636 38150-38157 NCBITaxon:33208 denotes animals
T635 38298-38306 CHEBI:36357;CHEBI:36357 denotes molecule
T634 38362-38366 PG_7;PR:000001341 denotes DPP4
T633 38395-38399 SP_9 denotes MERS
T632 38413-38418 NCBITaxon:10239 denotes viral
T631 38429-38433 PG_7;PR:000001341 denotes DPP4
T630 38448-38453 NCBITaxon:10239 denotes virus
T629 38465-38478 NCBITaxon:11118 denotes coronaviruses
T628 38522-38529 NCBITaxon:10239 denotes viruses
T627 38576-38580 G_3;PG_10;PR:000003622 denotes ACE2
T626 38641-38648 NCBITaxon:10239 denotes viruses
T625 38669-38673 UBERON:0002048 denotes lung
T624 38747-38751 G_3;PG_10;PR:000003622 denotes ACE2
T623 38796-38804 GO:0042571 denotes antibody
T622 38855-38864 SP_7 denotes 2019-nCoV
T621 39023-39032 SP_7 denotes 2019-nCoV
T620 39147-39155 CHEBI:36357;CHEBI:36357 denotes molecule
T619 23979-23983 G_3;PG_10;PR:000003622 denotes ACE2
T618 24067-24075 GO:0042571 denotes antibody
T617 24081-24089 CHEBI:36357;CHEBI:36357 denotes molecule
T616 24113-24124 NCBITaxon:11118 denotes coronavirus
T615 24248-24252 G_3;PG_10;PR:000003622 denotes ACE2
T614 24285-24294 PG_1 denotes S protein
T613 24298-24307 SP_7 denotes 2019-nCoV
T612 24333-24338 NCBITaxon:10239 denotes virus
T611 24379-24383 SP_10;NCBITaxon:10633 denotes SARS
T610 24384-24389 NCBITaxon:10239 denotes virus
T609 24447-24451 G_3;PG_10;PR:000003622 denotes ACE2
T608 24491-24495 SP_10;NCBITaxon:10633 denotes SARS
T607 24496-24501 NCBITaxon:10239 denotes virus
T606 24571-24575 G_3;PG_10;PR:000003622 denotes ACE2
T605 24584-24588 SP_10;PG_9 denotes SARS
T604 24589-24590 PG_9;PG_1 denotes S
T603 24591-24598 PG_1 denotes protein
T602 24664-24674 GO:0042571 denotes antibodies
T601 24697-24706 SP_7 denotes 2019-nCoV
T600 24732-24736 G_3;PG_10;PR:000003622 denotes ACE2
T599 24754-24758 G_3;PG_10;PR:000003622 denotes ACE2
T598 24832-24836 G_3;PG_10;PR:000003622 denotes ACE2
T597 24878-24892 GO:0019814 denotes immunoglobulin
T596 24896-24902 SO:0000417 denotes domain
T595 24904-24908 G_3;PG_10;PR:000003622 denotes ACE2
T594 24936-24944 UBERON:0000104 denotes lifespan
T593 24964-24972 CHEBI:36357;CHEBI:36357 denotes molecule
T592 24996-25004 CHEBI:35224;CHEBI:35224 denotes effector
T591 25022-25035 UBERON:0002405 denotes immune system
T590 25048-25053 NCBITaxon:10239 denotes virus
T589 25078-25084 NCBITaxon:33208 denotes animal
T588 25130-25134 G_3;PG_10;PR:000003622 denotes ACE2
T587 25135-25148 GO:0005576 denotes extracellular
T586 25149-25155 SO:0000417 denotes domain
T585 25169-25174 SP_6;NCBITaxon:9606 denotes human
T584 25180-25186 SO:0000417 denotes domain
T583 25188-25192 G_3;PG_10;PR:000003622 denotes ACE2
T582 25230-25234 SP_10 denotes SARS
T581 25235-25246 NCBITaxon:11118 denotes coronavirus
T580 25344-25348 G_3;PG_10;PR:000003622 denotes ACE2
T579 25376-25385 SP_7 denotes 2019-nCoV
T578 25457-25461 G_3;PG_10;PR:000003622 denotes ACE2
T577 25467-25476 SP_7 denotes 2019-nCoV
T576 25477-25486 PG_1 denotes S protein
T575 25514-25518 G_3;PG_10;PR:000003622 denotes ACE2
T574 25618-25622 SP_10 denotes SARS
T573 25627-25636 SP_7 denotes 2019-nCoV
T572 25692-25701 UBERON:0002048 denotes pulmonary
T571 25718-25729 UBERON:0001004 denotes respiratory
T570 25765-25772 NCBITaxon:10239 denotes viruses
T163 10656-10661 UBERON:0000170 denotes lungs
T162 10700-10705 SO:0000646 denotes siRNA
T161 10759-10764 UBERON:0000170 denotes lungs
T160 10855-10863 UBERON:0004821;CL:0000322 denotes alveolar
T159 10864-10874 CL:0000322;UBERON:0004821 denotes epithelial
T158 10875-10880 CL:0000322 denotes cells
T157 10888-10892 UBERON:0002048 denotes lung
T156 10897-10902 SO:0000646 denotes siRNA
T155 10976-10980 SO:0000704 denotes gene
T154 11032-11037 NCBITaxon:10239 denotes viral
T153 11088-11093 SO:0000646 denotes siRNA
T152 11183-11189 NCBITaxon:33208 denotes animal
T151 11238-11243 SO:0000646 denotes siRNA
T150 11326-11331 SO:0000646 denotes siRNA
T149 11332-11337 CHEBI:23888;CHEBI:23888 denotes drugs
T148 11378-11383 SO:0000646 denotes siRNA
T147 11503-11514 CHEBI:23888;CHEBI:23888 denotes medications
T146 6527-6537 GO:0042571 denotes antibodies
T145 6541-6550 SP_7 denotes 2019-nCoV
T144 6551-6562 NCBITaxon:11118 denotes Coronavirus
T143 6585-6594 PG_1 denotes S protein
T142 6631-6643 GO:0009986 denotes cell surface
T141 6683-6696 GO:0005886 denotes cell membrane
T140 6713-6718 NCBITaxon:10239 denotes viral
T139 6719-6731 GO:0000786 denotes nucleocapsid
T138 6763-6774 GO:0006260 denotes replication
T137 6783-6792 PG_1 denotes S protein
T136 6925-6934 PG_1 denotes S protein
T135 7000-7008 GO:0042571 denotes antibody
T134 7023-7032 PG_1 denotes S protein
T133 7051-7060 SP_7 denotes 2019-nCoV
T132 7219-7225 SO:0001026 denotes genome
T131 7238-7247 SP_7 denotes 2019-nCoV
T130 7300-7304 SO:0000704;GO:0006412 denotes gene
T129 7339-7349 GO:0010467 denotes expressing
T128 7354-7363 PG_1 denotes S protein
T127 7370-7379 CHEBI:60816;CHEBI:60816 denotes immunogen
T126 7414-7418 NCBITaxon:10088 denotes mice
T125 7422-7429 NCBITaxon:9986 denotes rabbits
T124 7447-7457 GO:0042571 denotes antibodies
T123 7564-7571 GO:0010467 denotes express
T122 7572-7580 GO:0042571 denotes antibody
T121 7645-7650 NCBITaxon:10239 denotes viral
T120 7700-7708 GO:0042571 denotes antibody
T119 7774-7780 NCBITaxon:33208 denotes animal
T118 7822-7831 SP_7 denotes 2019-nCoV
T117 8033-8041 GO:0042571 denotes antibody
T116 8066-8079 NCBITaxon:11118 denotes coronaviruses
T115 8080-8087 NCBITaxon:species denotes species
T114 8093-8097 SP_10 denotes SARS
T113 8146-8153 BV_9 denotes epitope
T112 8187-8197 GO:0042571 denotes antibodies
T111 8220-8226 SO:0000417 denotes domain
T110 8234-8243 PG_1 denotes S protein
T109 8396-8404 CHEBI:60004;CHEBI:60004 denotes cocktail
T108 8408-8418 GO:0042571 denotes antibodies
T107 8617-8624 GO:0010467 denotes express
T106 8654-8663 NCBITaxon:1 denotes organisms
T105 8668-8675 BV_20 denotes protein
T104 8676-8686 BV_20;GO:0010467 denotes expression
T103 8688-8696 NCBITaxon:2 denotes bacteria
T102 8705-8711 NCBITaxon:6960 denotes insect
T101 8833-8843 GO:0042571 denotes antibodies
T100 8852-8861 SP_7 denotes 2019-nCoV
T99 8862-8871 PG_1 denotes S protein
T98 8899-8906 NCBITaxon:33208 denotes animals
T97 8908-8913 NCBITaxon:9940 denotes sheep
T96 8915-8919 NCBITaxon:9925 denotes goat
T95 8921-8924 NCBITaxon:9913 denotes cow
T94 8935-8944 SP_7 denotes 2019-nCoV
T93 8945-8954 PG_1 denotes S protein
T92 8986-8996 GO:0042571 denotes antibodies
T91 9006-9013 NCBITaxon:33208 denotes animals
T90 9204-9210 NCBITaxon:33208 denotes animal
T89 9238-9246 UBERON:0001977 denotes antisera
T88 9260-9268 GO:0042571 denotes antibody
T87 9292-9298 NCBITaxon:33208 denotes animal
T86 9331-9336 SP_6;NCBITaxon:9606 denotes human
T85 9337-9343 UBERON:0002405;GO:0006959 denotes immune
T84 9344-9352 GO:0006959 denotes response
T83 9369-9384 GO:0019814 denotes immunoglobulins
T82 9394-9401 NCBITaxon:species denotes species
T81 9577-9586 SP_7 denotes 2019-nCoV
T80 2273-2280 GO:0040007 denotes growing
T79 2314-2323 UBERON:0002048 denotes pneumonia
T78 2384-2395 NCBITaxon:11118 denotes coronavirus
T77 2397-2406 SP_7 denotes 2019-nCoV
T76 2455-2459 SP_10 denotes SARS
T75 2501-2505 SP_9 denotes MERS
T74 2522-2526 SP_10 denotes SARS
T73 2531-2535 SP_9 denotes MERS
T72 2618-2622 SP_10 denotes SARS
T71 2740-2744 SP_10 denotes SARS
T70 2766-2772 NCBITaxon:9606 denotes people
T69 2788-2794 GO:0016265 denotes deaths
T68 2857-2868 NCBITaxon:11118 denotes coronavirus
T67 2870-2879 SP_7 denotes 2019-nCoV
T66 2953-2958 SP_6;NCBITaxon:9606 denotes Human
T65 2962-2967 SP_6;NCBITaxon:9606 denotes human
T64 2984-2993 SP_7 denotes 2019-nCoV
T63 3177-3186 SP_7 denotes 2019-nCoV
T62 3212-3217 UBERON:0002048 denotes cough
T61 3273-3278 UBERON:0001443 denotes chest
T60 3381-3392 NCBITaxon:1 denotes individuals
T59 3451-3456 NCBITaxon:10239 denotes virus
T58 3568-3579 NCBITaxon:11118 denotes coronavirus
T57 3807-3811 SP_10 denotes SARS
T56 3839-3850 NCBITaxon:10376 denotes Ebola virus
T55 3961-3972 NCBITaxon:1 denotes individuals
T54 4220-4224 SP_10 denotes SARS
T53 4228-4233 NCBITaxon:10376 denotes Ebola
T52 4367-4376 SP_7 denotes 2019-nCoV
T51 4571-4575 CHEBI:23888;CHEBI:23888;GO:0017144 denotes drug
T50 4576-4587 GO:0017144 denotes development
T49 4673-4678 GO:0016265 denotes dying
T48 5066-5071 NCBITaxon:10239 denotes virus
T47 5140-5149 SP_7 denotes 2019-nCoV
T46 5151-5156 NCBITaxon:10376 denotes Ebola
T45 5264-5270 NCBITaxon:33208 denotes animal
T44 5314-5323 SP_7 denotes 2019-nCoV
T43 5381-5392 NCBITaxon:11118 denotes coronavirus
T42 5444-5455 CHEBI:60816;CHEBI:60816 denotes immunogenic
T41 5520-5524 SP_10 denotes SARS
T40 5529-5533 SP_9 denotes MERS
T39 5686-5695 SP_7 denotes 2019-nCoV
T38 5764-5773 SP_7 denotes 2019-nCoV
T37 5809-5814 NCBITaxon:10376 denotes Ebola
T36 5998-6007 SP_7 denotes 2019-nCoV
T35 6008-6013 NCBITaxon:10239 denotes virus
T34 6160-6169 SP_7 denotes 2019-nCoV
T33 6229-6238 SP_7 denotes 2019-nCoV
T31 161-172 NCBITaxon:11118 denotes coronavirus
T30 174-183 SP_7 denotes 2019-nCoV
T29 246-251 NCBITaxon:10239 denotes viral
T28 356-367 NCBITaxon:1 denotes individuals
T27 451-460 SP_7 denotes 2019-nCoV
T26 563-572 SP_7 denotes 2019-nCoV
T25 674-679 GO:0016265 denotes death
T24 729-738 SP_7 denotes 2019-nCoV
T23 897-901 CHEBI:23888;CHEBI:23888 denotes drug
T22 950-958 GO:0042571 denotes antibody
T21 1014-1019 NCBITaxon:10239 denotes viral
T20 1024-1030 SO:0001026 denotes genome
T19 1209-1214 NCBITaxon:10239 denotes virus
T18 1278-1287 SP_7 denotes 2019-nCoV
T17 1325-1330 NCBITaxon:10239 denotes viral
T16 1341-1372 PG_10;PR:000003622 denotes angiotensin-converting enzyme 2
T15 1374-1378 G_3;PG_10;PR:000003622 denotes ACE2
T14 1393-1407 GO:0019814 denotes immunoglobulin
T11 1454-1462 GO:0042571 denotes antibody
T10 1496-1501 NCBITaxon:10239 denotes viral
T9 1544-1557 UBERON:0002405 denotes immune system
T8 1589-1593 G_3;PG_10;PR:000003622 denotes ACE2
T7 1637-1641 G_3;PG_10;PR:000003622 denotes ACE2
T6 1656-1661 UBERON:0000170 denotes lungs
T5 1712-1723 UBERON:0001004 denotes respiratory
T4 1801-1805 G_3;PG_10;PR:000003622 denotes ACE2
T3 1888-1895 BV_20 denotes protein
T2 1896-1906 BV_20;GO:0010467 denotes expression
T1 1934-1938 CHEBI:23888;CHEBI:23888 denotes drug
T13 1411-1417 SO:0000417 denotes domain
T12 1419-1423 G_3;PG_10;PR:000003622 denotes ACE2
T32 66-77 NCBITaxon:11118 denotes coronavirus
T420 32864-32868 G_3;PG_10;PR:000003622 denotes ACE2
T419 32869-32882 GO:0005576 denotes extracellular
T418 32883-32889 SO:0000417 denotes domain
T417 32958-32962 PR:000014459;SP_10;PG_9 denotes SARS
T416 32963-32964 PG_9;PG_1;PR:000005292 denotes S
T415 32965-32972 PG_1;PR:000005292 denotes protein
T414 32988-32992 G_3;PG_10;PR:000003622 denotes ACE2
T413 33092-33096 G_3;PG_10;PR:000003622 denotes ACE2
T412 33109-33113 UBERON:0002048 denotes lung
T411 33158-33162 G_3;PG_10;PR:000003622 denotes ACE2
T410 33255-33263 GO:0042571 denotes antibody
T409 33298-33307 SP_7 denotes 2019-nCoV
T408 33338-33342 PR:000001483 denotes CD16
T407 33407-33417 GO:0042571 denotes antibodies
T406 33421-33425 SP_9 denotes MERS
T405 33618-33622 G_3;PG_10;PR:000003622 denotes ACE2

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 950-958 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T2 1020-1023 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T3 1024-1030 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T4 1393-1407 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T5 1454-1462 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T6 1544-1557 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T7 1656-1661 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T8 1809-1816 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T9 1888-1895 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T10 3273-3278 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T11 5366-5373 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T12 5472-5479 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T13 6587-6594 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T14 6631-6643 Body_part denotes cell surface http://purl.org/sig/ont/fma/fma67653
T15 6631-6635 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T16 6683-6696 Body_part denotes cell membrane http://purl.org/sig/ont/fma/fma63841
T17 6683-6687 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T18 6743-6747 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T19 6785-6792 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T20 6852-6857 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T21 6885-6890 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T22 6927-6934 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T23 7000-7008 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T24 7025-7032 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T25 7219-7225 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T26 7300-7304 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T27 7356-7363 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T28 7572-7580 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T29 7700-7708 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T30 7757-7761 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T31 8033-8041 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T32 8236-8243 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T33 8668-8675 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T34 8712-8717 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T35 8864-8871 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T36 8947-8954 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T37 9260-9268 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T38 9369-9384 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871
T39 9677-9680 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T40 9681-9687 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T41 9717-9725 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T42 9766-9769 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T43 9770-9776 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T44 9806-9809 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T45 9810-9816 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T46 9965-9968 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T47 10050-10053 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T48 10054-10060 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T49 10134-10137 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T50 10338-10344 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T51 10534-10539 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T52 10596-10601 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T53 10656-10661 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T54 10759-10764 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T55 10855-10880 Body_part denotes alveolar epithelial cells http://purl.org/sig/ont/fma/fma62499
T56 10875-10880 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T57 10888-10892 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T58 10976-10980 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T59 11895-11898 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T60 12435-12438 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T61 12653-12657 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T62 13240-13248 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T63 13389-13394 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T64 13565-13573 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T65 13890-13896 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T66 13912-13918 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T67 13975-13981 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T68 14035-14041 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T69 14265-14270 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T70 14804-14810 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T71 15336-15341 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T72 15396-15400 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T73 15534-15542 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T74 15599-15602 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T75 15656-15664 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T76 15901-15913 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T77 16014-16021 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T78 16029-16041 Body_part denotes cell surface http://purl.org/sig/ont/fma/fma67653
T79 16029-16033 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T80 16193-16197 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T81 16329-16333 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T82 16478-16485 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T83 16546-16559 Body_part denotes cell membrane http://purl.org/sig/ont/fma/fma63841
T84 16546-16550 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T85 16590-16593 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T86 16619-16625 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T87 16637-16641 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T88 16713-16718 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T89 17234-17241 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T90 17619-17627 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T91 17705-17717 Body_part denotes cell surface http://purl.org/sig/ont/fma/fma67653
T92 17705-17709 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T93 17874-17881 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T94 18004-18015 Body_part denotes amino acids http://purl.org/sig/ont/fma/fma82739
T95 18082-18086 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T96 18193-18201 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T97 18212-18217 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T98 18671-18678 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T99 18797-18804 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T100 18964-18972 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T101 19141-19148 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T102 19248-19258 Body_part denotes amino acid http://purl.org/sig/ont/fma/fma82739
T103 19357-19361 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T104 19517-19522 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T105 19722-19727 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T106 19736-19741 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T107 19766-19770 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T108 19792-19799 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T109 19807-19817 Body_part denotes human body http://purl.org/sig/ont/fma/fma305853
T110 19835-19842 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T111 19903-19908 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T112 19921-19925 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T113 20075-20082 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T114 20200-20208 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T115 20225-20233 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T116 20436-20443 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T117 20591-20599 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T118 20624-20631 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T119 20790-20798 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T120 21021-21029 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T121 21096-21103 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T122 21192-21200 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T123 21338-21345 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T124 21544-21548 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T125 21981-21988 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T126 22159-22163 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T127 22216-22223 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T128 22693-22697 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T129 22877-22881 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T130 22902-22906 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T131 22955-22972 Body_part denotes endothelial cells http://purl.org/sig/ont/fma/fma66772
T132 22967-22972 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T133 22985-22992 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T134 23102-23114 Body_part denotes cell surface http://purl.org/sig/ont/fma/fma67653
T135 23102-23106 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T136 23162-23169 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T137 23320-23325 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T138 23355-23360 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T139 23466-23470 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T140 23533-23540 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T141 23587-23591 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T142 23592-23598 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T143 23634-23642 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T144 23704-23708 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T145 24067-24075 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T146 24155-24160 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T147 24287-24294 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T148 24517-24522 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T149 24591-24598 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T150 24878-24892 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T151 25022-25035 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T152 25479-25486 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T153 25825-25832 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T154 25851-25858 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T155 25913-25920 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T156 25968-25975 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T157 26008-26012 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T158 26069-26077 Body_part denotes hormones http://purl.org/sig/ont/fma/fma12278
T159 26491-26512 Body_part denotes cardiovascular system http://purl.org/sig/ont/fma/fma7161
T160 26986-26993 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T161 27011-27027 Body_part denotes immunoglobulin G http://purl.org/sig/ont/fma/fma62872
T162 27085-27096 Body_part denotes amino acids http://purl.org/sig/ont/fma/fma82739
T163 27141-27148 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T164 27329-27336 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T165 27423-27427 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T166 27523-27530 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T167 27573-27581 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T168 27637-27644 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T169 27741-27748 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T170 27822-27827 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T171 27880-27887 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T172 27997-28011 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T173 28120-28130 Body_part denotes amino acid http://purl.org/sig/ont/fma/fma82739
T174 28162-28169 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T175 28211-28222 Body_part denotes amino acids http://purl.org/sig/ont/fma/fma82739
T176 28248-28255 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T177 28310-28326 Body_part denotes immunoglobulin G http://purl.org/sig/ont/fma/fma62872
T178 29062-29077 Body_part denotes dendritic cells http://purl.org/sig/ont/fma/fma273565
T179 29072-29077 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T180 29079-29090 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T181 29096-29116 Body_part denotes natural killer cells http://purl.org/sig/ont/fma/fma63147
T182 29111-29116 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T183 29179-29184 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T184 29431-29436 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T185 29521-29528 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T186 29596-29604 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T187 29783-29790 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T188 29816-29820 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T189 30009-30016 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T190 30055-30062 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T191 30679-30682 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T192 30736-30739 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T193 30759-30766 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T194 30875-30878 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T195 30879-30884 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T196 30890-30893 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T197 30918-30921 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T198 30958-30965 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T199 31112-31115 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T200 31301-31304 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T201 31424-31427 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T202 31485-31489 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T203 31555-31558 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T204 31784-31787 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T205 32001-32005 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T206 32148-32155 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T207 32263-32270 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T208 32351-32355 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T209 32504-32514 Body_part denotes amino acid http://purl.org/sig/ont/fma/fma82739
T210 32675-32682 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T211 32775-32782 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T212 32814-32823 Body_part denotes histidine http://purl.org/sig/ont/fma/fma82755
T213 32965-32972 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T214 33072-33079 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T215 33109-33113 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T216 33255-33263 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T217 33353-33358 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T218 34175-34179 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T219 34594-34601 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T220 34726-34730 Body_part denotes Gene http://purl.org/sig/ont/fma/fma74402
T221 34787-34790 Body_part denotes DNA http://purl.org/sig/ont/fma/fma74412
T222 34794-34798 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T223 35286-35294 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T224 35924-35931 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T225 35958-35965 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T226 36140-36148 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T227 36740-36744 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T228 36752-36759 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T229 36950-36957 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T230 37297-37301 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T231 37361-37365 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T232 37393-37400 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T233 37461-37468 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T234 37509-37516 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T235 37647-37655 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T236 38669-38673 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T237 38796-38804 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1544-1557 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T2 3273-3278 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T3 9564-9569 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T4 10888-10892 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T5 11300-11305 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T6 13389-13394 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T7 14265-14270 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T8 19766-19770 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T9 22715-22721 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T10 22902-22906 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T11 22928-22934 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T12 23466-23470 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T13 23587-23591 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T14 23592-23598 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T15 23704-23708 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T16 25022-25035 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T17 26008-26012 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T18 26491-26512 Body_part denotes cardiovascular system http://purl.obolibrary.org/obo/UBERON_0004535
T19 27423-27427 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T20 32351-32355 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T21 33109-33113 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T22 34175-34179 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T23 38669-38673 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid_AGAC

Id Subject Object Predicate Lexical cue
p4463s12 12880-12890 MPA denotes polymerase
p4504s27 19605-19614 NegReg denotes eliminate
p4551s19 25859-25868 NegReg denotes decreased
p4551s20 25869-25879 MPA denotes expression
p4580s38 30031-30037 MPA denotes levels
p4588s25 31211-31220 PosReg denotes enhancing
p4588s26 31221-31229 MPA denotes affinity
p4596s33 32890-32899 NegReg denotes abolished
p4596s34 32900-32909 Enzyme denotes peptidase
p4596s35 32910-32918 MPA denotes activity
p4596s39 32933-32937 MPA denotes high
p4596s40 32938-32946 MPA denotes affinity
p4596s41 32947-32954 Interaction denotes binding
p4619s14 36459-36466 NegReg denotes reduced
p4619s15 36467-36471 Protein denotes ACE2

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 451-470 Disease denotes 2019-nCoV infection http://purl.obolibrary.org/obo/MONDO_0100096
T2 461-470 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T3 578-587 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T4 1669-1678 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T5 2223-2232 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T6 2314-2323 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T7 2420-2453 Disease denotes Severe Acute Respiratory Syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T8 2455-2459 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T9 2522-2526 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T10 2618-2622 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T11 2740-2744 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T12 3177-3196 Disease denotes 2019-nCoV infection http://purl.obolibrary.org/obo/MONDO_0100096
T13 3187-3196 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T14 3247-3256 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T15 3807-3811 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T16 3839-3844 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T17 4220-4224 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T18 4228-4233 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T19 4885-4890 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T20 5151-5156 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T21 5520-5524 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T22 5809-5814 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T23 7844-7853 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T24 8093-8097 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T25 10374-10378 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T26 10777-10786 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T27 11032-11047 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T28 11038-11047 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T29 11113-11118 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T30 11871-11887 Disease denotes immunodeficiency http://purl.obolibrary.org/obo/MONDO_0021094
T31 11904-11915 Disease denotes hepatitis C http://purl.obolibrary.org/obo/MONDO_0005231
T32 11904-11913 Disease denotes hepatitis http://purl.obolibrary.org/obo/MONDO_0002251
T33 12183-12188 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T34 12551-12555 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T35 13354-13364 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T36 13523-13538 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T37 13529-13538 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T38 13727-13736 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T39 13769-13778 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T40 14232-14237 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T41 14425-14434 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T42 15723-15728 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T43 16380-16384 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T44 16739-16743 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T45 16846-16850 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T46 16900-16904 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T47 17023-17032 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T48 17036-17040 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T49 17556-17565 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T50 17867-17871 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T51 18074-18078 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T52 18129-18133 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T53 18230-18239 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T54 18385-18389 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T55 18504-18508 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T56 19334-19349 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T57 19340-19349 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T58 20003-20012 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T59 20088-20092 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T60 20652-20671 Disease denotes 2019-nCoV infection http://purl.obolibrary.org/obo/MONDO_0100096
T61 20662-20671 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T62 20730-20734 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T63 21292-21304 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T64 22136-22140 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T65 22211-22215 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T66 22276-22285 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T67 22830-22839 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T68 23303-23312 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T69 23544-23548 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T70 23698-23715 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T72 23709-23715 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T73 23820-23829 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T74 23871-23886 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T75 23877-23886 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T76 24379-24383 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T77 24491-24495 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T78 24584-24588 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T79 25193-25195 Disease denotes NN http://purl.obolibrary.org/obo/MONDO_0009747
T80 25230-25234 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T81 25564-25573 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T82 25618-25622 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T83 25627-25646 Disease denotes 2019-nCoV infection http://purl.obolibrary.org/obo/MONDO_0100096
T84 25637-25646 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T85 25655-25664 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T86 25692-25707 Disease denotes pulmonary edema http://purl.obolibrary.org/obo/MONDO_0006932
T87 25712-25747 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T88 25718-25747 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T89 25749-25753 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T90 25793-25797 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T91 26002-26019 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T93 26013-26019 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T94 26169-26173 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T95 26217-26226 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T96 26230-26239 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T97 26375-26379 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T98 26766-26770 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T99 26860-26864 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T100 27134-27138 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T101 27428-27434 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T102 27773-27777 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T103 28881-28893 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T104 29319-29323 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T105 29397-29401 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T106 29649-29658 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T107 29880-29884 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T108 29991-29995 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T109 30048-30052 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T110 30239-30243 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T111 30332-30341 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T112 30943-30952 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T113 31376-31392 Disease denotes immunodeficiency http://purl.obolibrary.org/obo/MONDO_0021094
T114 31766-31775 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T115 31810-31819 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T116 32356-32362 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T117 32654-32658 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T118 32958-32962 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T119 33114-33120 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T120 34180-34186 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T121 34980-34989 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T122 35397-35401 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T123 36376-36385 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T124 36559-36563 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T125 37833-37837 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T126 38616-38620 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T127 38663-38680 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T129 38674-38680 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T130 38855-38874 Disease denotes 2019-nCoV infection http://purl.obolibrary.org/obo/MONDO_0100096
T131 38865-38874 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 118-122 http://purl.obolibrary.org/obo/CLO_0008416 denotes peer
T2 118-122 http://purl.obolibrary.org/obo/CLO_0050081 denotes peer
T3 153-154 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T4 222-223 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 306-313 http://purl.obolibrary.org/obo/CLO_0009985 denotes focused
T6 419-420 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T7 1146-1147 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T8 1209-1214 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T9 1255-1256 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T10 1300-1301 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T11 1408-1410 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T12 1424-1426 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T13 1439-1440 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T14 1544-1557 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T15 1594-1596 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T16 1656-1661 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T17 1752-1753 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18 1806-1808 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T19 2044-2045 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20 2092-2093 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 2194-2195 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T22 2286-2287 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23 2376-2377 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 2825-2837 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T25 2953-2958 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes Human
T26 2962-2967 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T27 2994-2997 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T28 3273-3278 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T29 3356-3359 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T30 3451-3456 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T31 3500-3501 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T32 3554-3556 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T33 3745-3752 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T34 3845-3850 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T35 4294-4296 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T36 4307-4308 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T37 4351-4361 http://purl.obolibrary.org/obo/UBERON_0001456 denotes are facing
T38 4398-4404 http://purl.obolibrary.org/obo/UBERON_0001456 denotes facing
T39 4618-4619 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T40 4907-4908 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T41 5007-5008 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T42 5066-5071 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T43 5242-5248 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T44 5264-5270 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T45 5589-5590 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T46 5616-5617 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T47 5984-5985 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T48 6008-6013 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T49 6027-6032 http://purl.obolibrary.org/obo/CLO_0009985 denotes focus
T50 6065-6071 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T51 6361-6363 http://purl.obolibrary.org/obo/CLO_0050475 denotes my
T52 6435-6442 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T53 6606-6607 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T54 6631-6635 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T55 6683-6687 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T56 6688-6696 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T57 6743-6747 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T58 6852-6857 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T59 6885-6890 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T60 6985-6986 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T61 7300-7304 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T62 7747-7753 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T63 7757-7761 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T64 7774-7780 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T65 7902-7908 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T66 8247-8248 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T67 8261-8263 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T68 8283-8284 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T69 8394-8395 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T70 8654-8663 http://purl.obolibrary.org/obo/OBI_0100026 denotes organisms
T71 8654-8663 http://purl.obolibrary.org/obo/UBERON_0000468 denotes organisms
T72 8688-8696 http://purl.obolibrary.org/obo/NCBITaxon_2 denotes bacteria
T73 8712-8717 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T74 8899-8906 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animals
T75 8908-8913 http://purl.obolibrary.org/obo/NCBITaxon_9940 denotes sheep
T76 8915-8919 http://purl.obolibrary.org/obo/NCBITaxon_9925 denotes goat
T77 9006-9013 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animals
T78 9097-9100 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T79 9171-9174 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T80 9204-9210 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T81 9292-9298 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T82 9331-9336 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T83 9462-9464 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T84 9469-9470 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T85 9529-9530 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T86 10027-10032 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T87 10379-10384 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T88 10459-10460 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T89 10534-10539 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T90 10656-10661 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T91 10759-10764 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T92 10795-10796 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T93 10864-10892 http://purl.obolibrary.org/obo/CL_0000082 denotes epithelial cells in the lung
T94 10944-10945 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T95 10976-10980 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T96 11030-11031 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T97 11183-11189 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T98 11201-11203 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T99 11279-11280 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T100 11341-11342 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T101 11865-11870 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T102 11888-11893 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T103 11916-11921 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T104 12065-12068 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T105 12653-12657 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T106 12701-12702 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T107 12750-12755 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T108 12895-12898 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T109 12930-12935 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T110 13048-13050 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T111 13052-13054 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T112 13289-13290 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T113 13435-13440 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T114 13476-13481 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T115 13496-13498 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T116 13552-13553 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T117 13695-13700 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T118 13890-13896 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T119 13912-13918 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T120 13975-13981 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T121 14035-14041 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T122 14512-14513 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T123 14572-14573 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T124 14804-14810 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T125 15316-15321 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T126 15336-15341 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T127 15511-15512 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T128 15556-15557 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T129 15603-15608 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T130 15645-15646 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T131 15942-15943 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T132 16029-16033 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T133 16064-16069 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T134 16193-16197 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T135 16207-16208 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T136 16314-16315 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T137 16329-16333 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T138 16340-16342 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T139 16425-16432 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T140 16533-16541 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T141 16546-16550 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T142 16551-16559 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T143 16594-16599 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T144 16637-16641 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T145 16713-16718 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T146 17345-17350 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T147 17566-17571 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T148 17669-17676 http://purl.obolibrary.org/obo/CLO_0009985 denotes focuses
T149 17705-17709 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T150 17887-17890 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T151 18025-18028 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T152 18082-18086 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T153 18212-18217 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T154 18344-18345 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T155 18729-18731 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T156 18856-18864 http://purl.obolibrary.org/obo/NCBITaxon_2 denotes bacteria
T157 18991-18992 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T158 19059-19062 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T159 19090-19102 http://purl.obolibrary.org/obo/OBI_0000245 denotes organization
T160 19173-19175 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T161 19290-19292 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T162 19357-19361 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T163 19486-19488 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T164 19517-19522 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T165 19562-19564 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T166 19615-19617 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T167 19635-19637 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T168 19722-19727 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T169 19736-19741 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T170 19766-19770 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T171 19766-19770 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T172 19807-19812 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T173 19903-19908 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T174 19921-19925 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T175 20309-20310 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T176 20448-20450 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T177 20533-20535 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T178 20538-20539 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T179 20896-20905 http://purl.obolibrary.org/obo/CLO_0036932 denotes hybridoma
T180 20935-20936 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T181 21115-21116 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T182 21268-21270 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T183 21415-21417 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T184 21488-21490 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T185 21517-21518 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T186 21544-21548 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T187 21742-21743 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T188 21802-21803 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T189 21904-21912 http://purl.obolibrary.org/obo/NCBITaxon_2 denotes bacteria
T190 22059-22061 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T191 22384-22391 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T192 22564-22565 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T193 22586-22587 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T194 22607-22609 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T195 22715-22721 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T196 22902-22906 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T197 22902-22906 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T198 22928-22934 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T199 22955-22972 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cells
T200 23102-23106 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T201 23320-23325 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T202 23355-23360 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T203 23466-23470 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T204 23466-23470 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T205 23505-23506 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T206 23524-23525 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T207 23556-23558 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T208 23587-23591 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T209 23587-23591 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T210 23704-23708 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T211 23704-23708 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T212 23836-23837 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T213 24007-24008 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T214 24155-24160 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T215 24223-24224 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T216 24333-24338 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T217 24384-24389 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T218 24496-24501 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T219 24517-24522 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T220 24707-24710 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T221 24762-24763 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T222 24893-24895 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T223 24909-24911 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T224 25022-25035 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T225 25048-25053 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T226 25065-25071 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T227 25078-25084 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T228 25092-25093 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T229 25169-25174 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T230 25262-25263 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T231 25349-25351 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T232 25465-25466 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T233 25591-25592 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T234 25765-25772 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T235 25976-25979 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T236 26008-26012 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T237 26008-26012 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T238 26199-26204 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T239 26306-26311 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T240 26408-26409 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T241 26491-26512 http://purl.obolibrary.org/obo/UBERON_0004535 denotes cardiovascular system
T242 26491-26512 http://www.ebi.ac.uk/efo/EFO_0000791 denotes cardiovascular system
T243 26517-26518 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T244 26585-26592 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T245 26723-26726 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T246 26794-26800 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T247 26826-26828 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T248 27003-27004 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T249 27005-27010 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T250 27028-27030 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T251 27047-27049 http://purl.obolibrary.org/obo/CLO_0001236 denotes 2A
T252 27097-27099 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T253 27254-27255 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T254 27355-27356 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T255 27391-27399 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T256 27423-27427 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T257 27423-27427 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T258 27570-27572 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T259 27778-27783 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T260 27822-27827 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T261 27870-27872 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T262 27891-27892 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T263 27934-27935 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T264 27991-27996 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T265 28012-28014 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T266 28055-28057 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T267 28113-28114 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T268 28152-28154 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T269 28223-28225 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T270 28237-28242 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T271 28304-28309 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T272 28394-28395 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T273 28406-28412 http://purl.obolibrary.org/obo/SO_0000418 denotes signal
T274 28418-28419 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T275 28420-28425 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T276 28515-28517 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T277 28537-28538 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T278 28815-28816 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T279 28834-28836 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T280 28848-28849 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T281 28992-28994 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T282 29062-29077 http://purl.obolibrary.org/obo/CL_0000451 denotes dendritic cells
T283 29096-29116 http://purl.obolibrary.org/obo/CL_0000623 denotes natural killer cells
T284 29179-29184 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T285 29213-29223 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T286 29285-29290 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T287 29317-29318 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T288 29324-29329 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T289 29342-29344 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T290 29406-29416 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T291 29420-29430 http://purl.obolibrary.org/obo/CL_0000234 denotes phagocytic
T292 29431-29436 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T293 29477-29482 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T294 29511-29513 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T295 29569-29570 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T296 29629-29630 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T297 29816-29820 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T298 29839-29842 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T299 29906-29911 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T300 29944-29945 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T301 29973-29978 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T302 30179-30180 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T303 30197-30202 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T304 30244-30249 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T305 30293-30298 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T306 30442-30447 http://purl.obolibrary.org/obo/UBERON_0001456 denotes faced
T307 30468-30470 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T308 30495-30496 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T309 30578-30579 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T310 30609-30610 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T311 30665-30668 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T312 30669-30671 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T313 30675-30678 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T314 30724-30725 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T315 30806-30809 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T316 30879-30884 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T317 30886-30889 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T318 31108-31111 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T319 31159-31160 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T320 31167-31174 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T321 31271-31279 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T322 31325-31340 http://purl.obolibrary.org/obo/NCBITaxon_9544 denotes rhesus macaques
T323 31370-31375 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T324 31393-31398 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T325 31414-31416 http://purl.obolibrary.org/obo/CLO_0054055 denotes 71
T326 31461-31468 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T327 31485-31495 http://purl.obolibrary.org/obo/CL_0000000 denotes cell types
T328 31594-31595 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T329 31735-31740 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T330 31902-31904 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T331 32038-32039 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T332 32059-32061 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T333 32313-32314 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T334 32351-32355 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T335 32351-32355 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T336 32366-32367 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T337 32433-32435 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T338 32537-32545 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T339 32910-32918 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T340 33109-33113 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T341 33109-33113 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T342 33170-33178 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T343 33325-33327 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T344 33353-33358 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T345 33366-33369 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T346 33623-33625 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T347 33675-33684 http://purl.obolibrary.org/obo/BFO_0000030 denotes objective
T348 33836-33845 http://purl.obolibrary.org/obo/BFO_0000030 denotes objective
T349 33947-33948 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T350 34095-34097 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T351 34108-34109 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T352 34175-34179 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T353 34175-34179 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T354 34192-34197 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T355 34282-34284 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T356 34499-34501 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T357 34571-34572 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T358 34624-34627 http://purl.obolibrary.org/obo/CLO_0002421 denotes CHO
T359 34624-34627 http://purl.obolibrary.org/obo/CLO_0052479 denotes CHO
T360 34624-34627 http://purl.obolibrary.org/obo/CLO_0052480 denotes CHO
T361 34624-34627 http://purl.obolibrary.org/obo/CLO_0052483 denotes CHO
T362 34624-34627 http://purl.obolibrary.org/obo/CLO_0052484 denotes CHO
T363 34624-34627 http://purl.obolibrary.org/obo/CLO_0052485 denotes CHO
T364 34726-34730 http://purl.obolibrary.org/obo/OGG_0000000002 denotes Gene
T365 34777-34779 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T366 34785-34786 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T367 34965-34967 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T368 35078-35079 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T369 35225-35230 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T370 35250-35252 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T371 35577-35579 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T372 35735-35736 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T373 36166-36171 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T374 36305-36307 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T375 36571-36576 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T376 36771-36772 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T377 36858-36863 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T378 36979-36981 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T379 37028-37033 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T380 37034-37036 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T381 37124-37127 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T382 37208-37210 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T383 37228-37234 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T384 37297-37301 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T385 37349-37350 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T386 37361-37365 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T387 37517-37518 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T388 37607-37609 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T389 37704-37705 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T390 37737-37739 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T391 37780-37781 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T392 37895-37896 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T393 38011-38018 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animals
T394 38150-38157 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animals
T395 38189-38190 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T396 38269-38270 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T397 38337-38338 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T398 38367-38369 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T399 38448-38453 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T400 38522-38529 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T401 38581-38583 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T402 38641-38648 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T403 38669-38673 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T404 38669-38673 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T405 38752-38754 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T406 38755-38758 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T407 39037-39039 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 897-901 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T2 975-990 Chemical denotes oligonucleotide http://purl.obolibrary.org/obo/CHEBI_7754
T3 1341-1352 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T4 1809-1816 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T5 1888-1895 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T6 1934-1938 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T7 1994-2000 Chemical denotes formal http://purl.obolibrary.org/obo/CHEBI_48341
T8 4195-4204 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T9 4571-4575 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T10 5366-5373 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T11 5472-5479 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T12 6587-6594 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T13 6785-6792 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T14 6927-6934 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T15 7025-7032 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T16 7356-7363 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T17 7370-7379 Chemical denotes immunogen http://purl.obolibrary.org/obo/CHEBI_60816
T18 8146-8153 Chemical denotes epitope http://purl.obolibrary.org/obo/CHEBI_53000
T19 8236-8243 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T20 8668-8675 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T21 8864-8871 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T22 8947-8954 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T23 9642-9658 Chemical denotes oligonucleotides http://purl.obolibrary.org/obo/CHEBI_7754
T24 9717-9725 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T25 9990-10006 Chemical denotes oligonucleotides http://purl.obolibrary.org/obo/CHEBI_7754
T26 10294-10309 Chemical denotes oligonucleotide http://purl.obolibrary.org/obo/CHEBI_7754
T27 10489-10505 Chemical denotes oligonucleotides http://purl.obolibrary.org/obo/CHEBI_7754
T28 10596-10601 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T29 10602-10615 Chemical denotes nanoparticles http://purl.obolibrary.org/obo/CHEBI_50803
T30 11332-11337 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T31 11557-11566 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T32 11635-11643 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T33 11644-11649 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T34 11809-11828 Chemical denotes protease inhibitors http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T36 11818-11828 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T37 11928-11937 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T38 12039-12048 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T39 12228-12236 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T40 12237-12242 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T41 12400-12423 Chemical denotes lopinavir and ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T42 12400-12409 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T43 12414-12423 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T44 12435-12458 Chemical denotes HIV protease inhibitors http://purl.obolibrary.org/obo/CHEBI_35660
T45 12439-12458 Chemical denotes protease inhibitors http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T47 12448-12458 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T48 12639-12649 Chemical denotes antivirals http://purl.obolibrary.org/obo/CHEBI_22587
T49 12703-12707 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T50 12836-12846 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T51 12992-12996 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T52 13214-13218 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T53 13609-13617 Chemical denotes antigens http://purl.obolibrary.org/obo/CHEBI_59132
T54 14798-14803 Chemical denotes donor http://purl.obolibrary.org/obo/CHEBI_17891
T55 14914-14923 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T56 14975-14983 Chemical denotes medicine http://purl.obolibrary.org/obo/CHEBI_23888
T57 15901-15913 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T58 16014-16021 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T59 16272-16283 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T60 16478-16485 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T61 17234-17241 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T62 17686-17697 Chemical denotes sialic acid http://purl.obolibrary.org/obo/CHEBI_26667
T63 17693-17697 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T64 17874-17881 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T65 18004-18015 Chemical denotes amino acids http://purl.obolibrary.org/obo/CHEBI_33709
T66 18004-18009 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T67 18010-18015 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T68 18193-18201 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T69 18797-18804 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T70 18964-18972 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T71 19141-19148 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T72 19248-19258 Chemical denotes amino acid http://purl.obolibrary.org/obo/CHEBI_33709
T73 19248-19253 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T74 19254-19258 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T75 19835-19842 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T76 20075-20082 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T77 20436-20443 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T78 20624-20631 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T79 21096-21103 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T80 21215-21223 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T81 21658-21662 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T82 22037-22046 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T83 22216-22223 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T84 23162-23169 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T85 23533-23540 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T86 24081-24089 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T87 24287-24294 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T88 24591-24598 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T89 24964-24972 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T90 24996-25004 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T91 25193-25195 Chemical denotes NN http://purl.obolibrary.org/obo/CHEBI_73406
T92 25479-25486 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T93 25825-25832 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T94 25851-25858 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T95 25913-25920 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T96 25968-25975 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T97 26039-26053 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T100 26039-26050 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T101 26051-26053 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T102 26069-26077 Chemical denotes hormones http://purl.obolibrary.org/obo/CHEBI_24621
T103 26100-26114 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T106 26100-26111 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T107 26112-26114 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T108 26525-26527 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T109 26585-26592 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T110 26986-26993 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T111 27085-27096 Chemical denotes amino acids http://purl.obolibrary.org/obo/CHEBI_33709
T112 27085-27090 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T113 27091-27096 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T114 27141-27148 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T115 27329-27336 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T116 27523-27530 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T117 27573-27581 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T118 27637-27644 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T119 27741-27748 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T120 27880-27887 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T121 28120-28130 Chemical denotes amino acid http://purl.obolibrary.org/obo/CHEBI_33709
T122 28120-28125 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T123 28126-28130 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T124 28162-28169 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T125 28211-28222 Chemical denotes amino acids http://purl.obolibrary.org/obo/CHEBI_33709
T126 28211-28216 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T127 28217-28222 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T128 28248-28255 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T129 28563-28567 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T130 28631-28635 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T131 28966-28974 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T132 29028-29036 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T133 29236-29245 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T134 29521-29528 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T135 29783-29790 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T136 30009-30016 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T137 30055-30062 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T138 30621-30630 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T139 30759-30766 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T140 30958-30965 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T141 31167-31174 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T142 32263-32270 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T143 32374-32376 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T144 32504-32514 Chemical denotes amino acid http://purl.obolibrary.org/obo/CHEBI_33709
T145 32504-32509 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T146 32510-32514 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T147 32675-32682 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T148 32775-32782 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T149 32814-32823 Chemical denotes histidine http://purl.obolibrary.org/obo/CHEBI_27570
T150 32965-32972 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T151 33072-33079 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T152 33638-33644 Chemical denotes Action http://purl.obolibrary.org/obo/CHEBI_5133
T153 34229-34237 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T154 34594-34601 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T155 34787-34790 Chemical denotes DNA http://purl.obolibrary.org/obo/CHEBI_16991
T156 35924-35931 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T157 35958-35965 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T158 36088-36095 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T159 36110-36118 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T160 36752-36759 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T161 36950-36957 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T162 37393-37400 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T163 37461-37468 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T164 37509-37516 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T165 37794-37798 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T166 38298-38306 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T167 39147-39155 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 6825-6834 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T2 7305-7314 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis
T3 9337-9352 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T4 9788-9799 http://purl.obolibrary.org/obo/GO_0009056 denotes degradation
T5 11032-11047 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T6 11694-11710 http://purl.obolibrary.org/obo/GO_0019058 denotes viral life cycle
T7 13523-13538 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T8 13574-13589 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T9 14641-14647 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T10 19334-19349 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T11 19400-19415 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T12 21292-21304 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T13 21586-21599 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T14 22188-22203 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T15 22359-22374 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T16 22488-22503 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T17 23871-23886 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T18 28396-28405 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T19 29246-29261 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T20 32527-32545 http://purl.obolibrary.org/obo/GO_0008233 denotes peptidase activity
T21 32900-32918 http://purl.obolibrary.org/obo/GO_0008233 denotes peptidase activity
T22 36088-36108 http://purl.obolibrary.org/obo/GO_0019882 denotes antigen presentation
T23 37302-37311 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-105 Sentence denotes Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China
T2 106-130 Sentence denotes [version 2; peer review:
T3 131-142 Sentence denotes 2 approved]
T4 144-152 Sentence denotes Abstract
T5 153-285 Sentence denotes A novel coronavirus (2019-nCoV) originating in Wuhan, China presents a potential respiratory viral pandemic to the world population.
T6 286-368 Sentence denotes Current efforts are focused on containment and quarantine of infected individuals.
T7 369-471 Sentence denotes Ultimately, the outbreak could be controlled with a protective vaccine to prevent 2019-nCoV infection.
T8 472-680 Sentence denotes While vaccine research should be pursued intensely, there exists today no therapy to treat 2019-nCoV upon infection, despite an urgent need to find options to help these patients and preclude potential death.
T9 681-870 Sentence denotes Herein, I review the potential options to treat 2019-nCoV in patients, with an emphasis on the necessity for speed and timeliness in developing new and effective therapies in this outbreak.
T10 871-1089 Sentence denotes I consider the options of drug repurposing, developing neutralizing monoclonal antibody therapy, and an oligonucleotide strategy targeting the viral RNA genome, emphasizing the promise and pitfalls of these approaches.
T11 1090-1238 Sentence denotes Finally, I advocate for the fastest strategy to develop a treatment now, which could be resistant to any mutations the virus may have in the future.
T12 1239-1584 Sentence denotes The proposal is a biologic that blocks 2019-nCoV entry using a soluble version of the viral receptor, angiotensin-converting enzyme 2 (ACE2), fused to an immunoglobulin Fc domain (ACE2-Fc), providing a neutralizing antibody with maximal breath to avoid any viral escape, while also helping to recruit the immune system to build lasting immunity.
T13 1585-1780 Sentence denotes The ACE2-Fc therapy would also supplement decreased ACE2 levels in the lungs during infection, thereby directly treating acute respiratory distress pathophysiology as a third mechanism of action.
T14 1781-2038 Sentence denotes The sequence of the ACE2-Fc protein is provided to investigators, allowing its possible use in recombinant protein expression systems to start producing drug today to treat patients under compassionate use, while formal clinical trials are later undertaken.
T15 2039-2179 Sentence denotes Such a treatment could help infected patients before a protective vaccine is developed and widely available in the coming months to year(s).
T16 2181-2193 Sentence denotes Introduction
T17 2194-2307 Sentence denotes A mysterious illness causing pneumonia in December 2019 in Wuhan, China is now growing into a potential pandemic.
T18 2308-2521 Sentence denotes These pneumonia cases were eventually characterized to be caused by a novel coronavirus (2019-nCoV) 1, of which Severe Acute Respiratory Syndrome (SARS) 2 and Middle East Respiratory Syndrome (MERS) 3 are members.
T19 2522-2617 Sentence denotes SARS and MERS famously caused their own outbreak concerns when they were originally identified.
T20 2618-2727 Sentence denotes SARS caused significant economic damage to Hong Kong and Southern China, before spreading to other countries.
T21 2728-2846 Sentence denotes Ultimately, SARS infected up to 8,098 people and caused 774 deaths according to the World Health Organization (WHO) 4.
T22 2847-2952 Sentence denotes The novel coronavirus, 2019-nCoV, is now quickly spreading across the world after originating in Wuhan 1.
T23 2953-3155 Sentence denotes Human-to-human transmission of 2019-nCoV has been confirmed in familial case cluster reports 5, as additional cases continue to be identified in different cities in China and countries around the world.
T24 3156-3297 Sentence denotes Clinical symptoms of 2019-nCoV infection include fever, cough, and myalgia or fatigue with pneumonia demonstrated on chest CT scan imaging 6.
T25 3298-3606 Sentence denotes Within China, the city of Wuhan along with several others has been shut down, with individuals not allowed to leave the city in an effort to contain the virus; such efforts are largely unprecedented in a city of this size ( https://www.nytimes.com/2020/01/22/world/asia/coronavirus-quarantines-history.html).
T26 3607-3755 Sentence denotes For now, many travelers are being screened for fever (≥38°C) and reported recent history of travel to Wuhan in order to triage diagnostic testing 7.
T27 3756-3873 Sentence denotes These efforts resemble not only what happened with SARS in 2002–2003, but also the Ebola virus outbreak in 2014–2015.
T28 3874-4013 Sentence denotes During those outbreaks, special protocols were put in place to quarantine any infected individuals and identify patient contacts at risk 8.
T29 4014-4170 Sentence denotes Healthcare workers were also at risk, and despite extensive personal protective equipment measures, clinical providers did get infected in both outbreaks 9.
T30 4171-4377 Sentence denotes There were no specific, antiviral treatments for SARS or Ebola at the time of the outbreaks beyond supportive measures 10, 11, which is a similar situation that healthcare systems are facing with 2019-nCoV.
T31 4378-4512 Sentence denotes The dire situations facing patients in outbreak scenarios demand quick responses by the healthcare community and the biotech industry.
T32 4513-4722 Sentence denotes Unfortunately, many of the traditional options that guide drug development are inadequate for outbreaks; a process that takes years can’t help patients who are dying today, and economies that are being halted.
T33 4723-4839 Sentence denotes In these situations, studies have often been conducted on compassionate use, and clinical trial approvals expedited.
T34 4840-4959 Sentence denotes This was most recently seen in the 2014–2015 Ebola outbreak, where a variety of clinical trial candidates were studied.
T35 4960-5075 Sentence denotes Many of these therapies failed, but ultimately a vaccine did emerge that was fully protective against the virus 12.
T36 5076-5309 Sentence denotes It is important to note that, unlike the current situation with 2019-nCoV, Ebola had already been studied for years and this particular neutralizing vaccine made and tested in preclinical animal models years prior to the outbreak 13.
T37 5310-5599 Sentence denotes For 2019-nCoV, beyond knowing the sequence of spike (S) protein of the coronavirus (GenBank: MN908947.3), there are no studies on how immunogenic this particular protein will be beyond surrogate comparisons to SARS and MERS, which limits the potential ability to quickly produce a vaccine.
T38 5600-5888 Sentence denotes Moreover, while a vaccine would be greatly effective in helping to stop the spread of 2019-nCoV, an effective therapy is also needed for the patients infected with 2019-nCoV today, similar to the situation of Ebola patients needing effective therapies while vaccines were being developed.
T39 5889-6170 Sentence denotes In this article, I will outline different potential treatment options that could be pursued as a therapy for 2019-nCoV virus, keeping the focus on agents that could be rapidly tested in patients today and broadly effective in spite of limited knowledge of the biology of 2019-nCoV.
T40 6171-6303 Sentence denotes Simply stated, there is limited time for basic studies of 2019-nCoV in research labs, while patients need effective therapies today.
T41 6304-6461 Sentence denotes I finally propose the best potential treatment option in my opinion, along with instructions on how to manufacture the therapy for testing in patients today.
T42 6463-6501 Sentence denotes Treatment strategies against 2019-nCoV
T43 6503-6550 Sentence denotes Developing neutralizing antibodies to 2019-nCoV
T44 6551-6778 Sentence denotes Coronavirus entry starts with the S protein binding to a target receptor on the cell surface, where after fusion is mediated at the cell membrane, delivering the viral nucleocapsid inside the cell for subsequent replication 14.
T45 6779-6984 Sentence denotes The S protein is famous for causing syncytial formation between infected cells and other receptor-bearing cells around them, emphasizing that the S protein does not function in just the virion state alone.
T46 6985-7195 Sentence denotes A neutralizing antibody targeting the S protein on the surface of 2019-nCoV is likely the first therapy contemplated by biomedical researchers in academia and industry, providing passive immunity to disease 15.
T47 7196-7380 Sentence denotes The recently published genome sequence of 2019-nCoV (GenBank: MN908947.3) allows researchers to perform gene synthesis in the lab and consider expressing the S protein as an immunogen.
T48 7381-7673 Sentence denotes Traditional methods of screening mice or rabbits for neutralizing antibodies may be too slow for this outbreak, but faster methods such as using phage or yeast display libraries that express antibody fragments could be used quickly to identify lead candidates for viral neutralization 16, 17.
T49 7674-7854 Sentence denotes The challenge is that any antibody candidate would need to be rigorously tested in cell culture and animal models to confirm that it can neutralize 2019-nCoV and prevent infection.
T50 7855-8042 Sentence denotes Furthermore, several isolates would need to be tested that are circulating in the population to try to assess if sufficient breadth of coverage is obtained with the neutralizing antibody.
T51 8043-8372 Sentence denotes Information from other coronaviruses species like SARS would be helpful as to where to target the best epitope in order to produce neutralizing antibodies (the receptor-binding domain in the S protein is a key target) 18, but again this is a slow and challenging process, which may not yield significant gains for several months.
T52 8373-8547 Sentence denotes Moreover, ultimately a cocktail of antibodies may be required to ensure full protection for patients, which would add additional complexity for formulation and manufacturing.
T53 8548-8781 Sentence denotes Like some of the therapeutic options discussed below, the ability to express any lead candidates in lower organisms for protein expression (bacteria, yeast, insect cells) would facilitate faster production of therapy for patients 19.
T54 8782-9017 Sentence denotes An alternative strategy of generating neutralizing antibodies against 2019-nCoV S protein would be to immunize large animals (sheep, goat, cow) with the 2019-nCoV S protein, and then purifying polyclonal antibodies from the animals 20.
T55 9018-9302 Sentence denotes This strategy may serve an expedited service in the setting of an outbreak and has many advantages such as simplifying production and manufacturing, but has limited guarantees that each animal would produce neutralizing antisera, or what the antibody titer would be in each animal 21.
T56 9303-9465 Sentence denotes Moreover, there is also the human immune response against foreign immunoglobulins to other species, which would potentially complicate any treatment scenarios 22.
T57 9466-9634 Sentence denotes In a truly desperate scenario, this strategy may be viable for a short-term, but would not easily scale in the 2019-nCoV outbreak, which is already rapidly multiplying.
T58 9636-9687 Sentence denotes Using oligonucleotides against 2019-nCoV RNA genome
T59 9688-9800 Sentence denotes Beyond targeting the surface proteins of 2019-nCoV, one could also target the RNA genome itself for degradation.
T60 9801-10064 Sentence denotes This RNA genome sequence of 2019-nCoV was recently published (GenBank: MN908947.3), and one strategy that could be considered then, is the use of small interfering RNA (siRNA) or antisense oligonucleotides (ASO) to combat the virus by targeting its RNA genome 23.
T61 10065-10112 Sentence denotes The challenge with this strategy is multi-fold.
T62 10113-10181 Sentence denotes First, the conserved RNA sequence domains of CoV-2019 are not known.
T63 10182-10319 Sentence denotes Identifying conserved sequences is essential in order to optimize siRNA targeting and avoid viral escape of the oligonucleotide strategy.
T64 10320-10458 Sentence denotes One could look at genome homology of 2019-nCoV to the SARS virus for comparison of conserved sequences, but this would still be guesswork.
T65 10459-10540 Sentence denotes A second challenge is how the oligonucleotides would be delivered into the lungs.
T66 10541-10665 Sentence denotes Advances have been made into delivery vehicles such as lipid nanoparticles that can mediate some delivery into the lungs 24.
T67 10666-10831 Sentence denotes It is unknown, however, if enough siRNA’s or ASO’s would be effectively delivered within the lungs to stop the infection or make a difference in its clinical course.
T68 10832-11048 Sentence denotes For example, if 25% of alveolar epithelial cells in the lung had siRNA or ASO in them, that efficiency might be a great success for traditional gene therapy, but would hardly make any difference in a viral infection.
T69 11049-11204 Sentence denotes Such an explanation is also likely why siRNA candidates against Ebola failed in trials 25, despite significant success in preclinical animal models 26, 27.
T70 11205-11369 Sentence denotes Lastly, even if one assumed that siRNA was effective clinically, there is a limited ability to scale up manufacturing of siRNA drugs to a large infected population.
T71 11370-11523 Sentence denotes Current siRNA and ASO therapies are manufactured for rare diseases, and there are no available resources existing to manufacture the medications quickly.
T72 11525-11578 Sentence denotes Repurposing currently available antiviral medications
T73 11579-11746 Sentence denotes Ideal agents to fight 2019-nCoV would be approved small molecule drugs that could inhibit different aspects of the viral life cycle, ultimately inhibiting replication.
T74 11747-11947 Sentence denotes Two classes of potential targets are viral polymerases 28 and protease inhibitors 29, both of which are components of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antiviral regimens.
T75 11948-12059 Sentence denotes Pilot clinical studies are already ensuing by desperate clinicians with various repurposed antiviral medicines.
T76 12060-12163 Sentence denotes This has been done in every viral outbreak previously with limited success, outside of case reports 30.
T77 12164-12321 Sentence denotes Indeed, during the Ebola outbreak, none of the repurposed small molecule drugs were definitively shown to improve the clinical course across all patients 31.
T78 12322-12559 Sentence denotes The 2019-nCoV could be different, and there are initial positive reports that lopinavir and ritonavir, which are HIV protease inhibitors, have some clinical efficacy against 2019-nCoV, similar to prior studies using them against SARS 32.
T79 12560-12804 Sentence denotes Research should continue to be undertaken to screen other clinically available antivirals in cell culture models of 2019-nCoV, in hopes that a drug candidate would emerge useful against the virus that could be rapidly implemented in the clinic.
T80 12805-12946 Sentence denotes One promising example could be remdesivir, which interferes with the viral polymerase and has shown efficacy against MERS in mouse models 33.
T81 12947-13055 Sentence denotes For further information, reviews of previous drug repurposing efforts for coronaviruses are provided 34, 35.
T82 13056-13230 Sentence denotes Though these repurposed medications may hold promise, it is still reasonable to pursue novel, 2019-nCoV specific therapies to complement potential repurposed drug candidates.
T83 13232-13288 Sentence denotes Passive antibody transfer from convalescent patient sera
T84 13289-13499 Sentence denotes A simple but potentially very effective tool that can be used in infectious outbreaks is to use the serum of patients who have recovered from the virus to treat patients who contract the virus in the future 36.
T85 13500-13631 Sentence denotes Patients with resolved viral infection will develop a polyclonal antibody immune response to different viral antigens of 2019-nCoV.
T86 13632-13829 Sentence denotes Some of these polyclonal antibodies will likely neutralize the virus and prevent new rounds of infection, and the patients with resolved infection should produce 2019-nCoV antibodies in high titer.
T87 13830-13963 Sentence denotes Patients with resolved cases of 2019-nCoV can simply donate plasma, and then this plasma can be transfused into infected patients 37.
T88 13964-14167 Sentence denotes Given that plasma donation is well established, and the transfusion of plasma is also routine medical care, this proposal does not need any new science or medical approvals in order to be put into place.
T89 14168-14370 Sentence denotes Indeed, the same rationale was used in the treatment of several Ebola patients with convalescent serum during the outbreak in 2014–2015, including two American healthcare workers who became infected 38.
T90 14371-14609 Sentence denotes As the outbreak continues, more patients who survived infection will become available to serve as donors to make antisera for 2019-nCoV, and a sizeable stock of antisera could be developed to serve as a treatment for the sickest patients.
T91 14610-14824 Sentence denotes Unfortunately, the exponential growth of the outbreak would work against this strategy, since the growing number of cases would likely outstrip the ability of previous patients to provide donor plasma as treatment.
T92 14825-14956 Sentence denotes Moreover, convalescent patient sera would have significant variability in the potency of antiviral effect, making it less ideal 37.
T93 14957-15165 Sentence denotes While transfusion medicine services should certainly pursue convalescent patient sera as an option right now for patient treatment, it is ultimately limited in its effective scope of controlling the outbreak.
T94 15167-15203 Sentence denotes Proposal for new 2019-nCoV therapies
T95 15204-15404 Sentence denotes The simplest and most direct approach to combating 2019-nCoV during the outbreak would be one to neutralize the virus from entering cells, the function that antibodies normally perform in the body 39.
T96 15405-15644 Sentence denotes For the reasons mentioned above when discussing neutralizing antibodies, it will be difficult to validate a broadly neutralizing antibody quickly, and a challenge to make sure that the mutating RNA virus will not escape its neutralization.
T97 15645-15796 Sentence denotes A cocktail antibody approach could be undertaken as was explored to treat the Ebola pandemic 40, but would add complexity to the manufacturing process.
T98 15797-15923 Sentence denotes However, there is another strategy to pursue in this scenario that does not rely on targeting the viral glycoprotein directly.
T99 15924-16107 Sentence denotes In this strategy, a neutralizing effect could be obtained by targeting the viral receptor protein on the cell surface, thereby blocking the virus from binding to it and gaining entry.
T100 16108-16206 Sentence denotes Fortunately, scientists have already uncovered the identity of the viral receptor in cell culture.
T101 16207-16415 Sentence denotes A recent pre-print publication found that the 2019-nCoV uses the angiotensin-converting enzyme 2 (ACE2) as a receptor for cell entry 41, which is the same receptor that the SARS coronavirus uses for entry 42.
T102 16416-16571 Sentence denotes For both viruses, the coronavirus binds to ACE2 through its S protein on the virion, where after fusion of the viral membrane and cell membrane will occur.
T103 16572-16719 Sentence denotes Subsequently, the RNA virus will replicate its genome inside the cell, and ultimately make new virions that will be secreted to infect other cells.
T104 16720-16886 Sentence denotes The coincidence of SARS and 2019-nCoV using ACE2 receptor opens up the possibility of using the extensive research studied on SARS entry and applying it to 2019-nCoV.
T105 16887-17048 Sentence denotes Based on the SARS literature, several potential blocking strategies could be considered, which were shown to be effective in preventing infection in SARS models.
T106 17050-17092 Sentence denotes Blocking agents that bind to ACE2 receptor
T107 17093-17188 Sentence denotes The first strategy would consist of administering to patients an agent that would bind to ACE2.
T108 17189-17330 Sentence denotes The key advantage here is that the host ACE2 protein will not change, so there is no concern about escape from binding the therapeutic agent.
T109 17331-17539 Sentence denotes Moreover, the virus will not have the ability to mutate and bind an entirely new host receptor in the time frame of this outbreak; such functional relationships are established by evolution over long periods.
T110 17540-17742 Sentence denotes By analogy, the influenza virus changes the mutations on its surface to escape antibody neutralization every year, but it always focuses on using sialic acid on the cell surface as an entry receptor 43.
T111 17743-17798 Sentence denotes There are two known options for agents to bind to ACE2.
T112 17799-17968 Sentence denotes The first is using the small receptor-binding domain (RBD) from the SARS S protein that has been shown to be the key domain that binds the ACE2 receptor during entry 44.
T113 17969-18098 Sentence denotes Administration of this domain, 193 amino acids in size, has been shown to effectively block the entry of SARS in cell culture 44.
T114 18099-18252 Sentence denotes It is well within reason that SARS RBD could be given to patients, thereby binding their ACE2 proteins on target cells, preventing infection ( Figure 1).
T115 18253-18362 Sentence denotes There is also the potential for the equivalent RBD of 2019-nCoV to be produced and used as a therapy as well.
T116 18363-18732 Sentence denotes This strategy assumes SARS and 2019-nCoV share the same binding site on ACE2, which is highly likely given the similar ACE2 binding sites of SARS and NL63 coronavirus The small size of the therapy, similar in size in nanobody domains from camelid antibodies, would enhance the perfusion of the biologic into tissues to more effectively bind to viral entry receptors 45.
T117 18733-18916 Sentence denotes In regards to the outbreak situation that is ongoing, the small protein facilitates the rapid production of the therapy in bacteria potentially, which would help production yields 19.
T118 18917-19117 Sentence denotes Moreover, bacterial production would allow RBD proteins to be produced in a wide range of production facilities today in China, which already has numerous contract research organization operations 46.
T119 19118-19276 Sentence denotes Alternatively, the RBD protein could be attached to an Fc fragment for extended circulation, which was done for an equivalent 212 amino acid domain from MERS.
T120 19277-19462 Sentence denotes The MERS RBD-Fc fusion demonstrated the ability to block viral infection toward cell receptors, as well as to stimulate an immune response against that specific viral domain in mice 47.
T121 19463-19638 Sentence denotes Of note, since the RBD-Fc fusion would bind to normal cells, one would want to eliminate cytotoxic Fc domain functions through mutations that eliminate Fc receptor binding 48.
T122 19639-19648 Sentence denotes Figure 1.
T123 19650-19728 Sentence denotes Therapeutic agents that could be used to block 2019-nCoV from infecting cells.
T124 19729-19818 Sentence denotes Target cells expressing ACE2 include lung and gastrointestinal tissues in the human body.
T125 19819-19932 Sentence denotes The large spike protein on the surface of the coronavirus binds to ACE2 on infected cells, leading to cell entry.
T126 19933-20013 Sentence denotes Three proposed strategies would block this interaction would abrogate infection.
T127 20014-20181 Sentence denotes In the first, the receptor-binding domain (RBD) of the spike protein from SARS or 2019-nCoV would be administered, thereby binding ACE2 and saturating available sites.
T128 20182-20308 Sentence denotes Alternatively, an antibody or single chain antibody fragment (scFv) could be administered against ACE2 to accomplish the same.
T129 20309-20444 Sentence denotes A third strategy would target the coronavirus virions directly by using the ACE2 extracellular domain as bait to bind to spike protein.
T130 20445-20537 Sentence denotes An Fc domain fused to ACE2 would facilitate prolonged circulation of the biologic (ACE2-Fc).
T131 20538-20684 Sentence denotes A second, similar strategy would be to administer an antibody that would bind to ACE2 protein, thereby preventing 2019-nCoV infection ( Figure 1).
T132 20685-20775 Sentence denotes This strategy was shown to effectively block SARS entry and replication in experiments 42.
T133 20776-20952 Sentence denotes While no ACE2 antibody sequences are published in literature indexes, monoclonal antibodies do exist and the associated hybridoma sequences could be cloned in a matter of days.
T134 20953-21104 Sentence denotes There would be no concern for any viral escape from an ACE2 binding antibody, which is an advantage over neutralizing approaches against the S protein.
T135 21105-21210 Sentence denotes There are a couple of design considerations when thinking about how to employ the ACE2 antibody strategy.
T136 21211-21362 Sentence denotes Any effector functions would need to be removed from the Fc domain 49, such that inflammation would not be caused in different tissues expressing ACE2.
T137 21363-21457 Sentence denotes This would retain the long-half life endowed by the Fc domain without any of the side effects.
T138 21458-21700 Sentence denotes The downside of including the Fc domain is the need to use a more expensive mammalian cell production system to preserve proper glycosylation, which would decrease the turnaround time for getting the drug to patients in the outbreak scenario.
T139 21701-21801 Sentence denotes Alternatively, one could just administer a single chain variable fragment (scFv) that binds to ACE2.
T140 21802-21876 Sentence denotes A nanobody or VHH domains from camelids are another option as well 50, 51.
T141 21877-21989 Sentence denotes These could be produced in bacteria, and its small size would allow for rapid permeation into different tissues.
T142 21990-22069 Sentence denotes The downside is the shorter half-life of these molecules without the Fc domain.
T143 22070-22121 Sentence denotes There are several limitations to these two options.
T144 22122-22406 Sentence denotes Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop.
T145 22407-22610 Sentence denotes Alternatively, if one were to use the homologous RBD from 2019-nCoV itself, this immune response would likely be very advantageous since it could yield both a blocking effect and a vaccination effect 52.
T146 22611-22840 Sentence denotes For both strategies, the dose that would be needed to block ACE2 receptors in the body across different organs is unknown, and as is the percentage of ACE2 receptors that would need to be saturated in order to slow the infection.
T147 22841-23050 Sentence denotes The number of ACE2 receptors in the body, which are found in lung and gastrointestinal organs along with vascular endothelial cells among other tissues 53, could ultimately prove prohibitive for this strategy.
T148 23051-23200 Sentence denotes Moreover, the turnover of the ACE2 receptor on the cell surface would also influence how often the therapeutic protein would need to be administered.
T149 23201-23378 Sentence denotes To solve this issue, one could increase the concentration of anti-ACE2 therapy at the crucial site of infection in the lungs, via local administration to lungs via nebulization.
T150 23379-23504 Sentence denotes Lastly, there is the possibility that binding ACE2 directly could paradoxically worsen lung physiology and clinical symptoms.
T151 23505-23719 Sentence denotes A study found that a fusion protein of SARS RBD to Fc domain bound ACE2 in murine lung tissue after administration, exacerbating alveolar edema via ACE2 interaction, which normally counteracts acute lung injury 54.
T152 23720-23887 Sentence denotes This suggests that if one were use an ACE2 binding strategy, it would be best employed early during infection or as a prophylaxis to block the initial viral infection.
T153 23888-23977 Sentence denotes Ultimately, clinical trials in patients would need to investigate these potential issues.
T154 23979-24006 Sentence denotes ACE2 immunoadhesin strategy
T155 24007-24181 Sentence denotes A potentially more promising strategy would be to create an antibody-like molecule that would bind to the coronavirus itself, rather than shielding cells from being infected.
T156 24182-24351 Sentence denotes For this strategy, it is proposed to use a soluble version of the ACE2 receptor that would bind to the S protein of 2019-nCoV thereby neutralizing the virus ( Figure 1).
T157 24352-24438 Sentence denotes Again, the research on the SARS virus suggests this strategy is potentially promising.
T158 24439-24537 Sentence denotes Soluble ACE2 receptor was demonstrated to block the SARS virus from infecting cells in culture 42.
T159 24538-24737 Sentence denotes The reported affinity of soluble ACE2 for the SARS S protein was 1.70 nM, which is comparable to the affinities of monoclonal antibodies 55; it is likely that 2019-nCoV has similar affinity for ACE2.
T160 24738-25054 Sentence denotes In order to use ACE2 as a therapy to treat patients, it would be advisable to convert soluble ACE2 into an immunoadhesin format fused to an immunoglobulin Fc domain (ACE2-Fc), thereby extending the lifespan of the circulating molecule, while also recruiting effector functions of the immune system against the virus.
T161 25055-25304 Sentence denotes While not tested in an animal model, a previous study demonstrated that an ACE2 extracellular domain fused to the human IgG1 domain (ACE2-NN-Ig) was effective in neutralizing SARS coronavirus in vitro, with a 50% inhibitory concentration of 2 nM 56.
T162 25305-25423 Sentence denotes This study provides evidence then that ACE2-Fc could similarly inhibit 2019-nCoV in vitro and potentially in patients.
T163 25424-25590 Sentence denotes An additional advantage of using ACE2 as a 2019-nCoV S protein neutralizing agent is that ACE2 administration could also directly treat the pneumonia pathophysiology.
T164 25591-25760 Sentence denotes A portion of patients with SARS and 2019-nCoV infection develop pneumonia, which is characterized by pulmonary edema and acute respiratory distress syndrome (ARDS) 1, 2.
T165 25761-25932 Sentence denotes The viruses may, in part, cause ARDS through viral-induced ACE2 protein shedding and ACE2 protein decreased expression, both of which are mediated by S protein binding 54.
T166 25933-26135 Sentence denotes Administration of recombinant ACE2 protein has been shown to improve acute lung injury through decreasing angiotensin II levels and the hormones subsequent binding to angiotensin II type 1a receptor 57.
T167 26136-26247 Sentence denotes Recombinant ACE2 can also reduce ARDS in respiratory syncytial virus 58 and H5N1 influenza 59 infection models.
T168 26248-26407 Sentence denotes Based on these promising preclinical studies, recombinant human ACE2 (rhACE2) was moved into clinical trials in order to treat ARDS in critically ill patients.
T169 26408-26516 Sentence denotes A phase I trial demonstrated rhACE2 was well tolerated with no effects seen on the cardiovascular system 60.
T170 26517-26670 Sentence denotes A phase II trial demonstrated on-target efficacy in reducing Ang1-8 peptide levels, but did not show significant modulation of respiratory parameters 61.
T171 26671-26887 Sentence denotes It remains to be seen whether rhACE2 administration has the same clinical benefits in treating ARDS that have been seen in animal models, and whether ACE2-Fc administration could alleviate ARDS in 2019-nCoV patients.
T172 26888-27051 Sentence denotes The proposed therapy for 2019-nCoV patients would consist of the extracellular domain of the ACE2 protein fused to a human immunoglobulin G Fc domain ( Figure 2A).
T173 27052-27238 Sentence denotes Studies have shown that the ACE2 amino acids 18 – 615 appear to be sufficient for SARS S protein binding 62, which also covers the peptidase domain necessary for ACE2 enzymatic function.
T174 27239-27435 Sentence denotes It is possible a smaller portion of the extracellular ACE2 domain would be adequate for S protein binding, although a smaller version would lack enzyme activity beneficial in treating lung injury.
T175 27436-27582 Sentence denotes Further studies are needed to define the minimal ACE2 domain necessary for 2019-nCoV S protein binding to construct even smaller ACE2-Fc proteins.
T176 27583-27828 Sentence denotes While we do not know the structure of the 2019-nCoV S protein or how it binds to the ACE2 receptor yet, it is reasonable for now to assume that the same ACE2 protein domains utilized by the SARS virus are also bound by 2019-nCoV to infect cells.
T177 27829-27838 Sentence denotes Figure 2.
T178 27840-27931 Sentence denotes TherapeuticDesign of the ACE2-Fc fusion protein as a therapy against 2019-nCoV coronavirus.
T179 27932-28050 Sentence denotes ( A) The extracellular domain of ACE2 is appended onto the human immunoglobulin Fc domain, including the hinge region.
T180 28051-28182 Sentence denotes The Fc domain facilitates dimerization of two ACE2 domains. ( B) The amino acid sequence of the ACE2-Fc fusion protein is provided.
T181 28183-28283 Sentence denotes The ACE2 domain consists of amino acids 18–615 of the human ACE2 protein (blue; UniProtKB - Q9BYF1).
T182 28284-28393 Sentence denotes The sequence of the human immunoglobulin G isotype 1 constant region is provided (green; UniProtKB - P01857).
T183 28394-28493 Sentence denotes A secretion signal from a human immunoglobin heavy chain is provided (red; UniProtKB - A0A0C4DH39).
T184 28494-28691 Sentence denotes The advantage of the Fc domain is endowing a longer-half life of the drug, which could enable healthcare workers to potentially be given drug doses prophylactically before seeing infected patients.
T185 28692-28897 Sentence denotes Indeed, the half-life of recombinant ACE2 was extended from less than two hours to over one week in mice when formatted as a recombinant ACE2-Fc therapy in a study evaluating treatment for hypertension 63.
T186 28898-29185 Sentence denotes One difference from the prior blocking agent strategies is that the effector functions of the Fc domain could be retained in this molecule, allowing recruitment of dendritic cells, macrophages, and natural killer cells through the CD16 receptor against viral particles or infected cells.
T187 29186-29492 Sentence denotes This may facilitate faster activation of the host antiviral immune response and elimination of the virus, which was illustrated in a SARS mouse model where Fc engaging antibodies were more potent in eliminating SARS via activation of phagocytic cells compared to antibodies that neutralized virus alone 64.
T188 29493-29827 Sentence denotes Overall, the ACE2-Fc fusion protein would have many of the same benefits of a traditional neutralizing antibody that would be sought as a treatment for the infection, but represent one with maximal breadth and potency since the 2019-nCoV could not escape its neutralization, given the same protein is also its receptor for cell entry.
T189 29828-30066 Sentence denotes Indeed, it has been shown that the pathogenicity of SARS versus the more mild human coronavirus NL63 was related to a lower affinity of NL63 for human ACE2 versus SARS, with NL63 S protein reducing ACE2 levels less than SARS S protein 65.
T190 30067-30203 Sentence denotes Therefore, if 2019-nCoV were to try to escape ACE2 neutralization via decreasing affinity, it would mutate into a less pathogenic virus.
T191 30204-30375 Sentence denotes This is similar to the re-emergent SARS virus in 2003-2004, which had lower affinity for human ACE2 and resulted in less severe infection and no secondary transmission 66.
T192 30376-30525 Sentence denotes Thus, 2019-nCoV could be presented with an evolutionary trap when faced with potential ACE2-Fc therapy, leading toward a more benign clinical course.
T193 30526-30754 Sentence denotes To give some additional support to the potential of a receptor-immunoadhesin being a potential antiviral strategy, it should be noted that CD4-Fc or CD4-IgG was one of the early agents developed as a potential HIV medication 67.
T194 30755-30885 Sentence denotes The protein contained the first two domains of the CD4 receptor that are known to bind gp120 on the surface of infected HIV cells.
T195 30886-30953 Sentence denotes CD4-IgG was shown to neutralize HIV in vitro, preventing infection.
T196 30954-31078 Sentence denotes The protein was also safe when administered in patients, although only limited-to-mild clinical benefit was achieved 68, 69.
T197 31079-31417 Sentence denotes Updated enhanced versions of CD4-IgG have been developed that additionally have a small peptide derived from the co-receptor, CCR5, enhancing affinity and giving even more potent neutralizing activity, essentially 100% of HIV isolates and making rhesus macaques resistant to multiple simian-human immunodeficiency virus challenges 70, 71.
T198 31418-31631 Sentence denotes While HIV and 2019-nCoV are very different viruses, with different cell types, kinetics, and clinical courses, the previous results with HIV are encouraging that this could be a therapeutic strategy for 2019-nCoV.
T199 31632-31864 Sentence denotes If anything, 2019-nCoV is likely more amenable to this neutralizing therapy given that the respiratory virus will only cause an acute infection, unlike HIV, which causes chronic infection in hosts with different cellular reservoirs.
T200 31865-32088 Sentence denotes One potential limitation of the ACE2-Fc strategy is that the increase in levels of extracellular ACE2 could have unknown effects on the body, particularly when elevated for a prolonged time via Fc domain extended half-life.
T201 32089-32235 Sentence denotes Small levels of extracellular ACE2 are already secreted by tissues, so the circulation of this extracellular domain would not be unprecedented 72.
T202 32236-32456 Sentence denotes Moreover, recombinant ACE2 protein was well-tolerated by healthy patients in a phase I trial, and by patients with lung injury in a phase II trial, suggesting treating 2019-nCoV patients with ACE2-Fc will also tolerated.
T203 32457-32683 Sentence denotes If investigators are still concerned, critical amino acid(s) for ACE2 peptidase activity could be mutated to abolish the native function of this sequence, while retaining high affinity binding for SARS and 2019-nCoV S protein.
T204 32684-32976 Sentence denotes Indeed, this possibility was previously investigated in generating an ACE2 and IgG1 fusion protein, which showed that mutation of histidine residues at position 374 and 378 of the ACE2 extracellular domain abolished peptidase activity, but retained high affinity binding to SARS S protein 56.
T205 32977-33196 Sentence denotes Of course, ACE2 peptidase mutation would eliminate the beneficial effects from the recombinant protein delivery of ACE2 in treating lung injury, so it is recommended that retaining ACE2 enzyme activity be pursued first.
T206 33197-33429 Sentence denotes Another potential concern is that receptor binding via an antibody format could inadvertently direct 2019-nCoV toward infecting Fc receptor (CD16) positive cells, which has been shown in vitro for neutralizing antibodies in MERS 73.
T207 33430-33532 Sentence denotes It’s unclear what clinical significance this would have, and to what extent this would happen in vivo.
T208 33533-33636 Sentence denotes Ultimately, clinical trials will be needed to delineate any specific side effects of ACE2-Fc treatment.
T209 33638-33664 Sentence denotes Action plan and discussion
T210 33665-33830 Sentence denotes The chief objective of global health efforts against 2019-nCoV remains to effectively quarantine patients and screen individuals who may be infected to limit spread.
T211 33831-33876 Sentence denotes That objective should continue going forward.
T212 33877-34059 Sentence denotes What is proposed here is an option to at least give infected patients a medication quickly to help alleviate symptoms and prevent death, while vaccine efforts for 2019-nCoV continue.
T213 34060-34250 Sentence denotes This could be enabled through ACE2-Fc providing a triple mechanism of action: (1) Treatment of ACE2 deficiency and lung injury, (2) virus neutralization, and (3) immune effector recruitment.
T214 34251-34363 Sentence denotes Beyond infected patients, ACE2-Fc could provide passive immunity to healthcare works at risk as another benefit.
T215 34364-34570 Sentence denotes Going forward, it is recommended that physicians, scientists, and biotech industry in China and elsewhere pursue manufacturing an ACE2-Fc biologic agent right now, which can immediately advance into trials.
T216 34571-34725 Sentence denotes A variety of different protein expression platforms (CHO, insect, yeast) could be utilized, depending on the particular contract manufacturer’s expertise.
T217 34726-34936 Sentence denotes Gene therapy could even be considered to make ACE2-Fc from a DNA or mRNA platform, but would have additional risk of uncertain delivery strategies and ultimately may slow down progress toward treating patients.
T218 34937-35231 Sentence denotes The goal would be that ACE2-Fc could treat infection in current patients preventing significant morbidities and death, while also serving as a potential prophylactic to give passive immunity to clinical providers on the frontlines, as well as individuals who may have been exposed to the virus.
T219 35232-35444 Sentence denotes Essentially, ACE2-Fc could be the potent neutralizing antibody that the global health community needs to combat 2019-nCoV, today, while also treating the underlying ARDS pathophysiology causing patient mortality.
T220 35445-35571 Sentence denotes It could be scaled much more quickly than convalescent patient sera, which would be dependent on infected individuals to make.
T221 35572-35728 Sentence denotes ACE2-Fc would be resistant to viral escape as well, unlike potential neutralizing monoclonal antibodies that may be developed in the coming weeks to months.
T222 35729-35966 Sentence denotes While a therapeutic strategy is being outlined here, the long-term goal of 2019-nCoV research would remain developing an effective vaccine to yield neutralizing antibodies, likely based on the S protein and specifically, the RBD protein.
T223 35967-36161 Sentence denotes Such trials should happen as soon as possible, but may prove to be challenging to get the right level of immunogenicity, antigen presentation, adjuvant addition, and potent antibody stimulation.
T224 36162-36256 Sentence denotes The virus could continue mutating, foiling different efforts to stimulate protective immunity.
T225 36257-36386 Sentence denotes By comparison, 2019-nCoV cannot escape the ACE2-Fc treatment strategy, since it leverages its own cognate receptor for infection.
T226 36387-36597 Sentence denotes As mentioned above, should 2019-nCoV attempt to escape this therapy via reduced ACE2 affinity binding, it would likely become less pathogenic, similar to the comparison of SARS versus human coronavirus NL63 65.
T227 36598-36864 Sentence denotes Lastly, scaling the dose of any effective vaccine would also prove to be challenging depending on the vector format (e.g. viral vector versus mRNA versus protein), and even a fully protective vaccine would not help patients who are currently infected with the virus.
T228 36865-37017 Sentence denotes In an effort to help aide researchers and industry in China to combat 2019-nCoV, the protein sequence of the ACE2-Fc construct is provided ( Figure 2B).
T229 37018-37188 Sentence denotes Different human Fc domains (IgG1, IgG2, IgG3, or IgG4) could be contemplated, although IgG1 traditionally has the most potency for triggering anti-microbial responses 49.
T230 37189-37285 Sentence denotes Similarly, an ACE2-Fc biologic without active ACE2 peptidase function could be explored as well.
T231 37286-37488 Sentence denotes Given that gene synthesis of this sequence could happen within a week, the gene could be placed within the protein expression platform of choice shortly thereafter leading to protein production quickly.
T232 37489-37703 Sentence denotes The availability of protein A columns and other techniques in the industry to purify antibodies would facilitate ACE2-Fc to quickly be repurposed on existing antibody manufacturing infrastructure existing in China.
T233 37704-37968 Sentence denotes A final benefit of pursuing ACE2-Fc is that it could effectively be used as a therapeutic drug stockpile for future outbreaks of SARS and 2019-nCoV, and any new coronavirus that emerges from a zoonotic reservoir in the future that uses the ACE2 receptor for entry.
T234 37969-38111 Sentence denotes Moreover, coronaviruses that replicate in animals across China and other countries could be studied in order to assess their entry mechanisms.
T235 38112-38321 Sentence denotes By understanding entry in these other animals, one could effectively predict a receptor that could be utilized in any zoonotic transmission event, and build a new receptor immunoadhesin molecule in the future.
T236 38322-38457 Sentence denotes As an example, a similar immunoadhesin, DPP4-Fc, could be envisioned for MERS based on the viral receptor, DPP4, used by that virus 74.
T237 38458-38575 Sentence denotes Beyond coronaviruses, this strategy could be utilized for other viruses where the risk of outbreak potential is high.
T238 38576-38734 Sentence denotes ACE2-Fc could also find use in treating ARDS for other unrelated viruses and causes of acute lung injury, building on the previous clinical trial work 60, 61.
T239 38735-39007 Sentence denotes In summary, ACE2-Fc has the potential to be the neutralizing antibody that healthcare workers need to treat and prevent 2019-nCoV infection today and could play an important role in the cessation of the outbreak if manufacturing based on an available sequence starts soon.
T240 39008-39156 Sentence denotes An alternative 2019-nCoV RBD-Fc fusion could also be pursued, if one desired the dual function of receptor blocking and vaccination in one molecule.
T241 39158-39175 Sentence denotes Data availability
T242 39177-39192 Sentence denotes Underlying data
T243 39193-39234 Sentence denotes No data are associated with this article.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 1712-1732 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T2 2223-2232 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T3 2314-2323 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T4 3205-3210 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T5 3212-3217 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T6 3223-3230 Phenotype denotes myalgia http://purl.obolibrary.org/obo/HP_0003326
T7 3234-3241 Phenotype denotes fatigue http://purl.obolibrary.org/obo/HP_0012378
T8 3247-3256 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T9 3654-3659 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T10 11871-11887 Phenotype denotes immunodeficiency http://purl.obolibrary.org/obo/HP_0002721
T11 11904-11913 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T12 23643-23648 Phenotype denotes edema http://purl.obolibrary.org/obo/HP_0000969
T13 23698-23715 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T14 25564-25573 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T15 25655-25664 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T16 25692-25707 Phenotype denotes pulmonary edema http://purl.obolibrary.org/obo/HP_0100598
T17 25718-25738 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T18 26002-26019 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T19 28881-28893 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T20 30325-30341 Phenotype denotes severe infection http://purl.obolibrary.org/obo/HP_0032169
T21 31376-31392 Phenotype denotes immunodeficiency http://purl.obolibrary.org/obo/HP_0002721
T22 31802-31819 Phenotype denotes chronic infection http://purl.obolibrary.org/obo/HP_0031035
T23 38663-38680 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320